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Abstract 
 
Introduction: Telomeres are nucleoprotein structures located at the ends of eukaryotic 
chromosomes, thought to protect the DNA from damage. As a person experiences stressors, 
harmful exposures, and other diseases throughout their life, telomeres are thought to become 
damaged and their length shortened, decreasing their ability to protect the DNA. Nutrition is an 
important aspect of healthy aging. Preservation of telomere length (TL) is thought to be one of 
the mechanisms by which good nutrition can delay or prevent the development of chronic 
disease and death. Recent evidence of preservation of TL with good nutrition is promising. Thus, 
the aim of this dissertation is to study the relationship of TL with nutrition and mortality, which 
will be accomplished through three distinct, but ancillary aims. The first aim of this research is to 
examine rates of age-related TL change and evaluate variability in the rate by gender, chronic 
stress, and chronic diseases. The second aim is to comprehensively examine the linear 
associations between different macro- and micro-nutrients and healthy eating and TL. The third 
aim is to assess the associations of TL with survival and lifespan.  
Methods: For the first and second study aim, cross-sectional data on individuals, aged ≥ 20 years 
with a TL measurement available, were included from the National Health and Nutrition 
Examination Survey, years 1999-2002. Crude and adjusted linear regression models were used to 
estimate the rate of decline in TL across 10-year age categories, and any variations in the decline 
with respect to sex, measure of chronic stress, and presence of chronic diseases. To evaluate the 
associations between TL and a variety of macro- and micro-nutrients, and healthy eating, 
multivariate linear regression models using energy-adjusted nutrients were implemented. For the 
third aim of the study, data on 328 elderly (oldest-old) men from the Zutphen (The Netherlands) 
and Cretan (Greece) Elderly Study, with available TL measurement in 2000 were included. 
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Follow-up for vital status was available until September 2015. Kaplan-Meier survival estimation 
assessed differences in survival between men with short and long TL. Univariate and 
multivariable Cox proportional hazard models assessed the associations of TL (standardized 
continuous measure) on survival. Linear regression models assessed the relation of TL on age at 
death.  
Results: In an adjusted model, the population rate of decline in TL with age was consistent and 
linear for only three age categories: 20-29 (β=-0.0196, 95% CI: -0.0360, -0.0032), 50-59 (β=-
0.0200, 95% CI: -0.0326, -0.0074) and 70-79 (β=-0.0164, 95% CI: -0.0318, -0.0010) years. The 
population rate of decline in TL with age was significantly greater for males and those with high 
allostatic load (a measure of chronic stress) and a history of comorbidities. When the population 
rate of decline in TL was analyzed by gender in 10-year age bins, a fairly consistent yet 
statistically non-significant decline for males was observed; however, a trough in the rate was 
observed for females in the age categories 20-29 years (β=-0.0283, 95% CI: -0.0468, -0.0099) 
and 50-59 years (β=-0.0216, 95% CI: -0.0396, -0.0036). To further elucidate the gender 
difference observed in the primary analyses, secondary analyses were conducted with 
reproductive and hormonal status; a significant inverse association was found between TL and 
parity, menopause, and age at menopause. In a linear regression model to study associations 
between TL and nutrients, adjusted for demographics and health-related behaviors, of the 
macronutrients examined, total fat (β= -83.24, 95% CI: -153.31, -13.17), mono-unsaturated (β= -
107.40, 95% CI: -175.39, -39.40) and poly-unsaturated fatty acids (β=-54.01, 95% CI: -99.81, -
8.19) were inversely associated with TL. Of the micro-nutrients examined, potassium was the 
only element (β= 90.17, 95% CI: 7.54, 172.79) and riboflavin or Vitamin B2 (β= 85.04, 95% CI: 
1.53, 168.54) was the only vitamin that was significantly associated with TL in fully adjusted 
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models. However, Vitamin A, B12, and E were inversely associated with TL in energy adjusted 
models. After adjustment for total calorie, demographic, and health-related behaviors, the overall 
healthy eating index (HEI) score was positively associated with TL (β= 3.42, 95% CI: 0.29, 6.53, 
p-value=0.033); every unit increase in HEI score increased the TL by 3.42 base pairs. In the 
mortality study, all but nine men were deceased by the end of the study period. TL was not 
related to socio-demographic factors, lifestyle factors and prevalent chronic diseases. Kaplan-
Meier survival analysis did not show statistically significant differences in all-cause or 
cardiovascular mortality between long and short TL groups. In Cox proportional hazards models, 
long TL was not associated with all-cause (HR: 0.90, 95%CI: 0.68 - 1.17) and cardiovascular 
mortality (HR: 0.96, 95%CI 0.62 - 1.50). In linear regression models, TL was not a significant 
predictor of age at death. Findings were also not significant when analyzed separately for the 
Zutphen and Cretan cohort. 
Conclusions: TL was shorter with increasing age and this decline was modified by gender, 
chronic stress and comorbidities; individuals with chronic morbidity and/or chronic stress and 
females in their twenties and fifties experienced greater decline. Female reproductive factors, 
i.e., parity and menopause, were associated with TL. Certain nutrients, as well as healthy eating 
in general, are associated with preservation of TL. Health gains associated with telomere 
preservation could potentially be achieved relatively easily through promotion of healthy and 
adequate diets. Finally, the lack of associations of TL with mortality and lifespan in the elderly 
men from Zutphen and Crete is consistent with previous literature. 
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Chapter 1. Introduction 
 
 Burgeoning geriatric populating 
Aging is a relatively new area of research as the proportion of elderly in the population grows 
globally, demanding attention for elderly health. Annually, around 58 million people celebrate 
their 60th birthday throughout the globe, a number equivalent to two persons becoming elderly 
every second (McNicoll, 2002). In 2012, about 11.5% of the total global population was 
represented by the elderly population and the proportion is expected to double by 2050 
(McNicoll, 2002). By 2050, estimates suggest that there will be more elderly (60 or over) than 
children under 15 years old in the world (McNicoll, 2002). This scenario of a growing geriatric 
population is also evident in the United States (US). The proportion of the US population (in 
2014) that was 65 or older was 14.5% (46.3 million) and this is projected to reach to 23.5% (98 
million) by 2060 (Colby & Ortman, 2015). The rapidly increasing growth rate of the proportion 
of geriatric individuals in the population has a direct and significant impact on the individual, 
family, society and the nation in social and economic constructs (Knickman & Snell, 2002; 
National Research Council Committee on Population, 2001).  
Health and quality of life (QoL) are major concerns for the aging population. A greater demand 
for geriatric health care is expected than ever before, and the geriatric population’s health 
management has become an increasing concern for both developing and developed countries in 
terms of funding and resources available (National Research Council Committee on Population, 
2001). During the life transition, various unique physical, mental and psycho-social changes 
accompany the phenomenon of aging (World Health Organization, 2015). With increasing age, 
people are more likely to experience multiple chronic diseases, which has a significant impact on 
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QoL and demand for health care. The impact on an individual with multiple chronic diseases is 
greater than the additive effect of individual conditions (Marengoni et al., 2011). In response, 
current research attention is focused on promoting a healthy aging experience and enhancing 
QoL in older adults (Centers for Disease Control and Prevention, 2003).   
 Elderly definition in research  
Although the global population is aging, a uniform definition of aging has not been established 
and, therefore, measuring aging can be difficult. Biologically, aging is inevitable in all living 
species, including human beings (Gilbert, 2000). Aging is defined by Gilbert et al as “the time-
related deterioration of the physiological functions necessary for survival and fertility” (Gilbert, 
2000). However, the definition is vague in itself and researchers have no clear cutoff for defining 
who is an elder.  
The demographics of aging is interesting, as well as complex. The literature identifies three 
different constructs of measuring aging: chronological, social, and biological aging. 
Chronological aging is simply a calculation of a number of years lived after birth. A limitation of 
the chronological age construct is that it cannot accurately differentiate an individual as young or 
elderly because two people of the same age may have different physical and mental functioning 
and life span (Choi, DiNitto, & Kim, 2014). 
Globally, the established criteria of aging come from a social construct and an individual is 
defined as elderly at the age they are eligible for retirement. In the US, it often coincides with 
eligibility for Social Security benefits. Based on the social definition (i.e., age eligible for 
retirement), developed and developing countries define elderly at different age cutoffs. In line 
with the United Nations, the developing countries use 60 years to refer to older people (United 
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Nations Population Fund, 2012; World Health Organization, 2002). In fact, most of the 
developed countries set the reference criteria at 60 years (United Nations Population Fund, 
2012). In the US, elderly, also called as senior citizens, are defined as the population aged 65 
years and above (Federal Interagency Forum on Aging-Related Statistics, 2016). But that number 
no longer holds the accepted status it once did. For example, the retirement age for Social 
Security benefit eligibility has already been increased from 65 to 66 and is scheduled to rise to 
67 shortly (Moon, Guo, & McSorley, 2015). 
Within the research literature and the health surveys on aging, differences in the defined age 
range are widespread. The survey on health, well-being, and aging in Latin America and the 
Caribbean includes persons aged 60 and older as elderly (Albala et al., 2005). The English 
longitudinal study of aging in United Kingdom (Steptoe, Breeze, Banks, & Nazroo, 2013) and 
the health and retirement study in the US (Sonnega et al., 2014) includes individuals over age 50 
years as elderly. Similarly, World Health Organization’s study on global aging and adult health 
collects data on adults aged 50 years and older (Chatterji, 2013). Such inconsistencies do not 
only limit the comparability of any research finding, but also obscure the translation of findings 
into clinical or public health practice.  
Political, social and research entities clearly have inconsistencies in the definitions of aging. 
From a clinical and public health perspective, it is more important to study the biologically aged 
population. However, capturing biological aging is not as simple as counting numbers of years 
since birth. Telomere length (TL) has been proposed as a candidate biomarker of aging (Butler et 
al., 2004; Guralnik, 2008; von Zglinicki & Martin-Ruiz, 2005). Additionally, TL is also 
considered as a biomarker of health status, disease risk and early mortality. 
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 Biomarkers of aging 
Human aging is a complex process, and despite extensive efforts to develop the biomarkers of 
human aging, success so far has been limited (Sprott, 2010). The American Federation for Aging 
Research (AFAR) proposed that biomarkers of aging (Lara et al., 2015; Simm et al., 2008):  
1. must predict the rate of aging (it should tell exactly where a person is in their total 
lifespan and it must be a better predictor of lifespan than chronological age);  
2. it must monitor a basic process that underlies the aging process, not the effects of 
disease;  
3. it must be able to be tested repeatedly without harming the person (for example a blood 
test or an imaging technique);  
4. it must be something that works in humans and in laboratory animals, such as mice (so 
that it can be tested in laboratory animals before being validated in humans).  
Biomarkers meeting all of the above criteria are practically implausible (Johnson, 2006). In a 
2005 review of the in-vitro and in vivo evidence, von Zglinicki and Martin-Ruiz (von Zglinicki 
& Martin-Ruiz, 2005) stated that “as TL changes with age, has high inter-individual variability, 
is linked to basic biology, and correlates with aging and aging-related disease”, thus it satisfies 
several criteria for a biomarker of aging. Therefore, many research studies since then have 
advocated TL as a candidate biomarker of aging (Butler, et al., 2004; Guralnik, 2008; von 
Zglinicki & Martin-Ruiz, 2005).  
Telomeres, a nucleoprotein structures situated at the ends of eukaryotic chromosomes (Figure 
1-1), are called as the chromosome’s protective cap due to their role in protecting the end of the 
chromosome from degradation and end-to-end fusion (Blackburn, Greider, & Szostak, 2006). 
Additionally, telomeres play a vital role in preserving our genomic information by protecting the 
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genome from nucleolytic degradation, unnecessary recombination, and repair (Shammas, 2011). 
With each somatic cell division, there is a gradual attrition of the telomere, resulting in TL 
shortening with increasing age (Slagboom, Droog, & Boomsma, 1994). However, TL decreases 
are not directly proportional with age. TL decreases have also been associated with stressors, 
occurrence of chronic disease, obesity, etc. (Haycock et al., 2014; Sampson, Winterbone, 
Hughes, Dozio, & Hughes, 2006; van der Harst et al., 2007; Weischer et al., 2012; Wikgren et 
al., 2012). TL has been proposed as a candidate biomarker of aging (von Zglinicki & Martin-
Ruiz, 2005) whereby longer TL is an indicator of healthy aging (Cherkas et al., 2008). Several 
human studies provide support for this proposed hypothesis by providing evidence to suggest 
that TL is inversely related to several age-sensitive measures (Aviv, 2006; Houben, Moonen, van 
Schooten, & Hageman, 2008), such as oxidative stress (Demissie et al., 2006; Houben, et al., 
2008), diabetes (Sampson, et al., 2006), and heart disease (Brouilette et al., 2007; Haycock, et 
al., 2014; van der Harst, et al., 2007; Weischer, et al., 2012), as well as overall mortality 
(Needham et al., 2015; Rode, Nordestgaard, & Bojesen, 2015).
 
Figure 1-1. Telomere in cell  
(Source: TA Science https://www.tasciences.com/what-is-a-telomere/) 
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 Study aims and hypotheses 
Preservation of TL among healthy individuals is thought to be one of the several ways for the 
prevention of chronic diseases and mortality. This research examines one of the several theories 
linking TL with chronic diseases and mortality. The aims of the proposed dissertation are to 
describe telomere rate of decline with age; generate initial hypotheses about specific nutritional 
factors and TL; and to assess the associations of TL with survival and lifespan. The dissertation 
will be operationalized in terms of three distinct, but ancillary research aims and hypotheses, as 
defined below: 
 Aim 1: To assess the cross-sectional rates of change in TL by age, and evaluate any 
variability in the rates by gender, measures of chronic stress and presence of chronic 
diseases.  
 Aim 2: To estimate the association between TL and nutritional factors, and healthy eating 
index (Basiotis, Carlson, Gerrior, Juan, & Lino, 2002). 
 Aim 3: To assess the association of TL with mortality and lifespan among elderly men. 
This dissertation follows the three-paper dissertation format. Thus, the subsequent chapters 
(Chapters 2, 3, and 4) are three unique manuscripts written in peer-reviewed journal style, 
reflecting the above three study aims. Chapter 5 presents an overall conclusion. 
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Chapter 2. Manuscript 1  
 
“Decline in Telomere Length by Age and Effect Modification by Gender, 
Allostatic Load and Comorbidities in National Health and Nutrition 
Examination Survey (1999-2002)” 
 
 Abstract 
 Background 
This study aims to assess the decline in telomere length (TL) with age and evaluate effect 
modification by gender, chronic stress, and comorbidity in a representative sample of the US 
population.  
 Methods  
Cross-sectional data on 7826 adults with a TL measurement were included from the National 
Health and Nutrition Examination Survey, years 1999-2002. The population rate of decline in TL 
across 10-year age categories was estimated using crude and adjusted regression. 
 Results 
In an adjusted model, the population rate of decline in TL with age was consistent and linear for 
only three age categories: 20-29 (β=-0.0196, 95% CI: -0.0360, -0.0032), 50-59 (β=-0.0200, 95% 
CI: -0.0326, -0.0074) and 70-79 (β=-0.0164, 95% CI: -0.0318, -0.0010) years. The population 
rate of decline in TL with age was significantly greater for males and those with high allostatic 
load (a measure of chronic stress) and a history of comorbidities. When the population rate of 
decline in TL was analyzed by gender in 10-year age bins, a fairly consistent yet statistically 
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non-significant decline for males was observed; however, a trough in the rate was observed for 
females in the age categories 20-29 years (β=-0.0283, 95% CI: -0.0468, -0.0099) and 50-59 years 
(β=-0.0216, 95% CI: -0.0396, -0.0036). To further elucidate the gender difference observed in 
the primary analyses, secondary analyses were conducted with reproductive and hormonal status; 
a significant inverse association was found between TL and parity, menopause, and age at 
menopause.  
 Conclusions  
TL was shorter with increasing age and this decline was modified by gender, chronic stress and 
comorbidities; individuals with chronic morbidity and/or chronic stress and females in their 
twenties and fifties experienced greater decline. Female reproductive factors, i.e., parity and 
menopause, were associated with TL.  
 Keywords  
Telomere Length, NHANES, Allostatic Load, Comorbidities 
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 Introduction  
Telomeres, nucleoprotein structures located at the ends of eukaryotic chromosomes, protect the 
end of the chromosome from degradation and end-to-end fusion (Blackburn, et al., 2006). With 
each somatic cell division, there is a gradual attrition of the telomere, resulting in telomere length 
shortening with increasing age (Blackburn, et al., 2006). Telomere length (TL) has been 
proposed as a candidate biomarker of aging (von Zglinicki & Martin-Ruiz, 2005) whereby longer 
TL is an indicator of healthy aging. Preservation of TL among healthy individuals, in comparison 
to those with multiple morbidities, is thought to be one of the several pathways by which the 
development of chronic diseases and mortality can be explained. Although the association 
between health status and TL has been fairly well established, it is unclear how quickly TL 
declines with increasing age, or whether there is any effect modification by gender, chronic 
stress and morbidities, all of which influence telomere dynamics (Ahrens, Rossen, & Simon, 
2016; Epel et al., 2004; Fuster & Andres, 2006; Gardner et al., 2014). 
Although TL shortens with increasing age (Slagboom, et al., 1994), TL decreases are not directly 
proportional with age. Gender, chronic stress, and comorbidities may modify the relationship 
between age and TL.  Females have longer telomeres than males (Gardner, et al., 2014). Chronic 
psychosocial stress, depression, anxiety, and childhood trauma was associated with shorter TL 
(Epel, et al., 2004; O'Donovan et al., 2011; Okereke et al., 2012; Simon et al., 2006; Tyrka et al., 
2010). Perceived stress was associated with lower telomerase activity, and shorter TL among 
healthy premenopausal women (Epel, et al., 2004). Shorter TL in adulthood was associated with 
childhood trauma (Tyrka, et al., 2010). Stressful life events within the last five years was 
associated with associated with shorter telomeres in Netherlands Study of Depression and 
Anxiety (Verhoeven, van Oppen, Puterman, Elzinga, & Penninx, 2015). A systematic review 
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aimed to examine whether chronic social stress is associated with TL throughout the life course, 
concluded that chronic social stress was associated with shorter telomeres in both early and adult 
exposures (Oliveira et al., 2016).  Further, evidence suggests that shorter telomeres is associated 
with greater cortisol reactivity to stress, central elements of the physiological stress response 
system (Gotlib et al., 2015; Tomiyama et al., 2012). "Allostatic load," also called the wear and 
tear in the body (McEwen & Seeman, 1999), has been proposed as a conceptualization of 
cumulative stress exacted on the body through attempts to adapt to life's demands (Seeman, 
McEwen, Rowe, & Singer, 2001). Stress, an inevitable condition of human existence, has been 
associated with poor health outcomes (McEwen & Seeman, 1999). Limited research has looked 
at the relationship between TL and allostatic load (Ahrens, et al., 2016). 
TL has been linked to various morbidities, such as diabetes (Sampson, et al., 2006), heart disease 
(Brouilette, et al., 2007; Haycock, et al., 2014; van der Harst, et al., 2007; Weischer, et al., 2012), 
hypertension (Yang et al., 2009) cancer (Zhu et al., 2016), and depression (Ridout, Ridout, Price, 
Sen, & Tyrka, 2016), as well as overall mortality (Needham, et al., 2015; Rode, et al., 2015). A 
meta-analysis of 62 population based studies found a non-significant association between short 
telomeres and overall risk of cancer, but an increased risk for gastrointestinal tumor and head and 
neck cancer, indicating that telomeres may play diverse roles for risk in different cancers (Zhu, et 
al., 2016). In contrast, a Mendelian Randomization Study reported an increased risk for several 
cancers with longer telomeres but reduced risk for cardiovascular diseases (CVD) (Haycock et 
al., 2017). Another meta-analysis reported negative association between depression and TL 
(Ridout, et al., 2016). The Charlson comorbidity index (CCI) is commonly used to provide a 
cumulative weighted score of 17 comorbid conditions (Charlson, Pompei, Ales, & MacKenzie, 
1987). The measure of decline in TL with age by allostatic load and comorbidities could be 
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useful, particularly in elucidating the biologic pathway by which chronic stress and 
comorbidities can affect TL and accelerate the rate of aging. Once this pathway is better 
understood, this information can be used to develop effective prevention measures in at-risk 
populations. Therefore, we aim to assess the decline in TL with age and evaluate any effect 
modification by gender, chronic stress and comorbidities in a representative sample of the US 
population. Guided by the results of the primary analyses and to further elucidate the observed 
gender differences, secondary analyses were conducted to examine the association between TL, 
parity and menopause. 
 Methods 
 Study design 
The National Health and Nutrition Examination Survey (NHANES) is a cross-sectional 
nationally representative survey of the US civilian noninstitutionalized population, conducted 
using complex, multistage, stratified, clustered sampling (Curtin et al., 2012; Johnson et al., 
2013b). Details of NHANES methodology have been reported elsewhere (Curtin, et al., 2012; 
Johnson, et al., 2013b). We used data from the cycles 1999-2000 and 2001-2002, combining 
them following the National Center for Health Statistics (NCHS) recommendations (Johnson, et 
al., 2013b).   
 Study participants 
NHANES 1999-2000 and 2001-2002 included a total of 9965 and 11,039 participants, 
respectively. For our analyses, we included those aged ≥ 20 years who had a measure of TL, for 
a total of 7826 individuals from both the cycles, NHANES 1999-2002. 
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 Ethical approval 
NHANES was approved by the NCHS Research Ethics Review Board 
(https://www.cdc.gov/nchs/nhanes/irba98.htm). All participants provided written informed 
consent. The Institutional Review Board at the University of Nevada Las Vegas approved the 
current study.   
 Measurements 
2.3.4.1 Telomere length 
Telomere length in leukocytes was measured from whole blood using the quantitative 
polymerase chain reaction method, described in detail elsewhere (Cawthon, 2002; Needham et 
al., 2013). The Mean T/S ratio, which is the measure of TL relative to standard reference DNA, 
were provided in the NHANES dataset. During data analysis, the T/S ratio was converted to 
kilobase pairs (kbp) using the following formula: (3,274 + 2,413 * (T/S))/1000.  
2.3.4.2 Allostatic load 
Chronic stress, a hypothesized effect modifier, was measured in terms of allostatic load, 
quantified using nine biomarkers of cardiovascular, inflammatory, and metabolic system 
functioning. The nine biomarkers with corresponding cutoffs (Chen, Redline, Shields, Williams, 
& Williams, 2014; Parente, Hale, & Palermo, 2013) were: systolic blood pressure ≥ 140 mm Hg, 
diastolic blood pressure ≥ 90 mm Hg, heart rate ≥ 90 beats/minute, total cholesterol level ≥ 240 
mg/dL, high-density lipoprotein (HDL) cholesterol < 40mg/dL, BMI ≥ 30 kg/m2, glycosylated 
hemoglobin ≥ 6.4%, C-reactive protein ≥ 0.3 mg/dL, and albumin < 3.8 g/dL. Each measure was 
coded as a dichotomous variable at the cutoff (1, if the respondent had indicated the condition; 0, 
if otherwise). The cumulative score of the nine indicators was then converted into a dichotomous 
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variable, with high allostatic load defined as an allostatic load score ≥ 3. The same cutoff values 
and measures have been used to quantify allostatic load with the NHANES dataset in previous 
studies (Chen, et al., 2014; Parente, et al., 2013). 
2.3.4.3 Comorbidity 
We calculated the Charlson Comorbidity Index (Charlson, et al., 1987), another hypothesized 
effect modifier, to account for the impact of any comorbid conditions on TL. Different health 
conditions included in calculating CCI, their definations and corresponding weights in the 
calculation, are provided in Appendix A. Because a score of ≥4 points is associated with an 
estimated 53% 10-year mortality, a weighted combined index score of ≥4 points was used to 
define a history of chronic comorbid conditions (Charlson, et al., 1987). 
2.3.4.4 Other covariates 
Covariates for this study, selected based on the literature, were race/ethnicity, educational 
attainment, socioeconomic status (SES), and body mass index (BMI) (Gardner, et al., 2014; 
Needham, et al., 2013; Rehkopf et al., 2016).  
Age (in years and 10-year categories), gender, race/ethnicity (nominal: Hispanic, Non- Hispanic 
[NH] white, NH Black, and others including multi-racial); educational level (ordinal: <12th 
grade, high school graduate/some college, and college graduate or above); and marital status 
(nominal: married/living with partner, divorced/widowed/separated, and never married) were 
self-reported by the participants. SES was measured on a continuous scale, in terms of poverty 
income ratio (PIR). PIR, the ratio of family income to the poverty threshold, was calculated 
following the U.S. Department of Health and Human Services’ poverty guidelines and described 
in detail elsewhere (Johnson, et al., 2013b). BMI, the ratio of weight/height2 measured in kg/m2, 
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was available as a continuous measure and was categorized as normal weight (<25 kg/m2), 
overweight (25- <30 kg/m2) and obese (≥30 kg/m2). Following the definition for menopause 
proposed by McKinlay (McKinlay, 1994), menopause was defined as one or more of the given 
criteria: over 55 years, had a hysterectomy or both ovaries removed, and menopause as the 
reason for no periods in the past 12 months. Age at menopause as well as number of pregnancies 
resulting in live birth were self-reported by women.  
 Statistical analyses 
To generate a nationally representative sample, we adjusted sample weights in the analyses 
following the NHANES guidelines to (Johnson, et al., 2013b). For nominal variables, 
percentages with 95% CIs are provided; for continuous variables, unadjusted means with 
standard error (SEM) are provided (Table 2-1). TL was divided into quartiles based on the 
weighted population distribution. Covariate characteristics, between the quartiles of TL, were 
compared using Rao-Scott Chi-Square tests and analysis of variance. Linear regression with TL 
(kbp) as the outcome was used to assess the association with socio-demographic factors, 
biomarkers of allostatic load, and reproductive factors among females. Initially, univariate 
models were evaluated, then a group of covariates (age, gender, race/ethnicity, education, PIR, 
and BMI) were added to the model.  
The main outcome of this study is rate of decline in TL, which would best use a longitudinal 
design study. Since this is a cross-sectional study, we aim to examine the cross-sectional rates of 
TL decline as a proxy for rate of decline in TL by age. For this, we are assuming that an 
individual with a TL at a certain age will, later in life, have the same TL as another individual at 
an older age with similar covariates. Therefore, the rate we are measuring is a population rate of 
decline in TL, not an individual rate of decline. To measure the population rate of decline in TL 
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in different age categories, we used 10-year bins and calculated the slope of the rate of decline in 
TL as a function of age in each bin, using a linear regression with TL (kbp) as outcome and age 
(years) as predictor. All population rates of decline in TL are adjusted for gender, ethnicity, CCI, 
and allostatic load. A two-tailed p-value less than 0.05 was considered statistically significant. 
Data analyses were performed using the survey procedures that account for the weights and 
complex survey design of NHANES, in SAS 9.4 (SAS Institute Inc., Cary, NC). 
 Results 
 Participant’s characteristics  
The mean (±SEM) age and TL of the participants were 45.2±0.4 years and 5.8±0.04 kbp, 
respectively (Table 2-1). Participants with shorter TL, i.e., in lower quartiles, were older, NH 
White, married, and had higher BMI, allostatic load, and CCI. A gradual decreasing trend in 
mean age, BMI, allostatic load and CCI was noted from lowest to highest quartiles (Table 2-1). 
 Telomere length and associated factors 
In analyses adjusted for age, gender, race/ethnicity, education, PIR, and BMI (Table 2-2), 
increasing age, having less than high school education, and higher BMI were associated with 
lower TL. Likewise, NH Black compared to NH White and unmarried compared to 
married/living with a partner had higher TL.  A further stratified analysis was conducted to 
assess the role of age and gender in the association between marital status and TL. We found that 
the marital status and TL association was significant only for younger (20-29 years) females (β: 
0.5194, 95%CI: 0.1129-0.9258, p-value: 0.0141) and older (80 years and above) females (β: 
0.2770, 95%CI: 0.1217-0.4323, p-value: 0.001). Although female gender demonstrated a 
positive trend and family PIR demonstrated an inverse trend with TL, the findings did not reach 
the statistical significance of <0.05 (Table 2-2). 
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Table 2-1. Socio-demographic characteristics of the study participants by quartiles of leukocyte telomere length- NHANES 
1999-2002 
 Overall (N=7826) Quartiles, % (95% CI) 
 N % (95% CI) One (N=2415) Two (N=2120) Three (N=1633) Four (N=1658) p-Value 
Age, years, mean ±SEM  7826 45.2 ±0.4 54.6 ±0.7 46.2 ±0.8 41.5 ±0.7 37.4 ±0.8 <0.001 a 
TL, kbp, mean ±SEMb 7826 5.8 ± 0.04 5.1 ±0.0 5.6 ±0.0 6.0 ±0.0 6.7 ±0.0 <0.001 a 
Gender        
 Male 3770 48.6 (47.6 - 49.5) 50.7 (48.3 - 53.2) 48.0 (45.1 - 50.9) 47.7 (45.5 - 49.9) 47.7 (45.2 - 50.3) 0.287 
 Female 4056 51.4 (50.5 - 52.4) 49.3 (46.8 - 51.7) 52.0 (49.1 - 54.9) 52.3 (50.1 - 54.5) 52.3 (49.7 - 54.8)  
Race/Ethnicity        
 Hispanic 2292 13.8 (9.7 - 17.8) 11.8 (6.0 - 17.7) 13.4 (9.3 - 17.4) 14.2 (9.7 - 18.6) 15.9 (11.1 - 20.6) <0.001 
 NH White 3965 72.8 (69.0 - 76.5) 77.4 (71.8 - 82.9) 74.7 (70.5 - 78.9) 71.1 (66.4 - 75.8) 67.2 (62.4 - 72.0)  
 NH Black 1333 9.4 (7.2 - 11.6) 7.2 (5.2 - 9.2) 8.1 (5.6 - 10.6) 9.8 (7.6 - 12.1) 12.8 (9.4 - 16.3)  
 Other 236 4.1 (2.7 - 5.4) 3.6 (1.8 - 5.5) 3.9 (2.7 - 5.0) 4.9 (3.1 - 6.7) 4.0 (1.8 - 6.3)  
Educational Status        
 <12th Grade 2640 21.3 (19.4 - 23.2) 26.3 (23.4 - 29.2) 20.6 (18.3 - 22.9) 20.8 (17.4 - 24.2) 17.1 (15.3 - 18.9) <0.001 
 High School/Some College 3733 54.6 (51.7 - 57.5) 53.0 (49.1 - 56.9) 55.2 (51.6 - 58.8) 52.1 (47.1 - 57.1) 57.9 (53.4 - 62.5)  
 College Graduate 1441 24.1 (20.7 - 27.5) 20.7 (16.8 - 24.6) 24.2 (20.7 - 27.7) 27.1 (21.6 - 32.7) 24.9 (19.8 - 30.1)  
Marital Status        
 Married/Living with Partner 4759 65.1 (63.0 - 67.2) 68.8 (66.4 - 71.1) 67.3 (64.2 - 70.3) 63.9 (60.5 - 67.3) 59.5 (55.7 - 63.3) <0.001 
 Divorced/Widowed/Separated 1566 17.5 (16.2 - 18.9) 23.0 (21.0 - 24.9) 19.4 (17.3 - 21.6) 14.4 (11.9 - 16.8) 12.1 (9.8 - 14.4)  
 Never Married 1123 17.4 (15.6 - 19.1) 8.3 (6.8 - 9.8) 13.3 (10.8 - 15.8) 21.8 (19.1 - 24.4) 28.4 (25.4 - 31.4)  
Family PIR, mean ±SEM 7128 3.0 ±0.1 3.0 ±0.1 3.1 ±0.1 3.1 ±0.1 2.8 ±0.1 <.0001 a 
BMI, kg/m2, mean ±SEM 7577 28.0 ±0.1 28.7 ±0.2 28.2 ±0.2 27.8 ±0.2 27.4 ±0.3 <.0001 a 
Allostatic load, mean± SEM b 7826 2.4 ±0.0 2.7 ±0.0 2.5 ±0.0 2.4 ±0.0 2.2 ±0.1 <0.001 a 
CCI, mean ±SEM b 7826 1.5 ±0.0 2.2 ±0.1 1.5 ±0.1 1.2 ±0.1 1.0 ±0.1 <0.001 a 
  
a: p-values from one-way ANOVA; all others from a Chi-square test. b SEM values of 0 indicates a value <0.1. Abbreviations: BMI: body mass index, CCI: Charleston’s comorbidity index, CI: 
confidence interval, Kbp: kilo base pairs, TL: telomere length, NH: Non-Hispanic, PIR: poverty income ratio, SEM: standard error of mean. Values expressed are % (95% CI) unless otherwise stated. 
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Table 2-2. Multivariable regression for factors associated with telomere length- NHANES 1999-2002 
  Model 1 unadjusted Model 2 adjusted a 
  β 95%CI p-value β 95%CI p-value 
 Age  -0.0146 -0.0162, -0.0130 <0.001 -0.0141 -0.0157, -0.0126 <0.001 
Gender (Reference= Male) 
      
 Female 0.0252 -0.0265, 0.0769 0.328 0.0425 -0.0071, 0.0921 0.0903 
Race/Ethnicity (Reference= NH White) 
      
 Hispanic 0.0681 -0.0692, 0.2054 0.319 -0.0044 -0.1391, 0.1302 0.9467 
 NH Black 0.1687 0.0802, 0.2572 <0.001 0.1257 0.0342, 0.2172 0.0088 
 Other 0.0396 -0.1005, 0.1797 0.568 -0.0237 -0.1634, 0.1160 0.7312 
Educational Status (Reference=High School) 
      
 <12th Grade -0.1203 -0.1825, -0.0581 <0.001 -0.0775 -0.1417, -0.0132 0.0198 
 College Graduate -0.0023 -0.0689, 0.0642 0.943 0.0285 -0.0363,0.0933 0.3754 
Marital Status (Reference= Married/with Partner) 
     
Divorced/Widowed/Separated -0.1111 -0.1655, -0.0566 <0.001 -0.0177 -0.0767, 0.0413 0.5445 
 Never Married 0.3162 0.2422, 0.3901 <0.001 0.0963 0.0257, 0.1669 0.009 
Family PIR -0.0127 -0.0354, 0.0100 0.261 -0.0043 -0.0281, 0.0194 0.7116 
Biomarkers of allostatic load       
Systolic blood pressure -0.0030 -0.0044, -0.0015 <0.001 0.0012 -0.0003, 0.0027 0.1105 
Diastolic blood pressure 0.0041 0.0022, 0.0060 <0.001 0.0007 -0.0001, 0.0023 0.4329 
Heart rate -0.0008 -0.0026, 0.0009 0.325 -0.0019 -0.0036, -0.0003 0.0237 
Total cholesterol -0.0002 -0.0007, 0.0004 0.516 0.0001 -0.0006, 0.0006 0.9649 
High-density lipoprotein cholesterol 0.0027 0.0009, 0.0044 0.004 0.0024 0.0003, 0.0045 0.0272 
BMI (kg/m2) -0.0093 -0.0133, -0.0052 <0.001 -0.0069 -0.0106, -0.0033 <0.001 
Glycosylated hemoglobin -0.0370 -0.0573, -0.0167 <0.001 -0.0054 -0.0302, 0.0194 0.6571 
C-reactive protein -0.0538 -0.0993, -0.0083 0.022 -0.0380 -0.0791, 0.0032 0.0692 
Albumin  0.1664 -0.3897, 0.7225 0.545 0.1664 -0.3897, 0.7225 0.5453 
Allostatic load (Reference=Low)       
High -0.1735 -0.2226, -0.1244 <0.001 -0.0351 -0.0927, 0.0225 0.2232 
Charleston Comorbidity Index -0.0723 -0.0823, -0.0624 <0.001 -0.0020 -0.0147, 0.0107 0.7501 
 
DV: Telomere length in kbp; a Adjusted for age, gender, race/ethnicity, education, PIR, and BMI (when applicable, the variable for which coefficient is reported, adjustments were made for the 
remaining variables). Abbreviations: BMI: body mass index, CI: confidence interval, NH: Non-Hispanic, PIR: poverty income ratio. p-value less than 0.05 are bold. 
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Of the nine biomarkers of allostatic load, after controlling for covariates, only the regression 
coefficients of heart rate, HDL cholesterol, and BMI had the 95% CIs that did not include the 
null of no association (Table 2-2); while a higher heart rate and BMI was associated with shorter 
TL, a higher value of HDL cholesterol preserved it. In an unadjusted analysis, a one-unit 
difference in allostatic load and CCI were associated with 17.3% and 7.2% decrease in TL, 
respectively. However, the estimates did not remain statistically significant when controlled for 
covariates. Specifically, age had a strong confounding effect on our estimates because most of 
the covariates with a significant coefficient in unadjusted models retained their statistical 
significance when adjusted for other covariates except age (Appendix B).  
 Cross-sectional population rates of telomere length decline 
The population rates of decline in TL stratified by 10-year age bins showed that decline in TL 
with age was initiated early in life (20-29 years) and was consistent and linear for only three age 
categories: 20-29 (β=-0.0196, 95% CI: -0.0360, -0.0032), 50-59 (β=-0.0200, 95% CI: -0.0326, -
0.0074) and 70-79 (β=-0.0164, 95% CI: -0.0318, -0.0010) years. The population rate of decline 
in TL was sharp in the age category 70-79 years; whereas, in the oldest age category examined 
(80-89 years), the rate of decline (β=-0.0103, 95% CI: -0.0412, 0.0207) was highly variable and 
did not follow a linear pattern. Likewise, the population rate of decline in TL stratified by 
allostatic load and comorbid conditions showed a significantly greater rate of decline among 
those with high allostatic load (β=-0.0123, 95% CI: -0.0143, -0.0102), and history of comorbid 
conditions (β=-0.0137, 95% CI: -0.0167, 0.0106).  
Gender stratified analyses, adjusted for ethnicity, CCI, and allostatic load, (Figure 2-1) showed a 
significantly greater rate of decline for males (β=-0.0153, 95% CI: -0.0170, -0.0135, p-value 
<0.001) compared to females (β=-0.0129, 95% CI: -0.0154, -0.0105, p-value <0.001). When the 
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population rate of decline in TL was further stratified by gender in 10-year age bin (Figure 2-2), 
we observed a fairly consistent population rate of decline in TL for males; none of the regression 
coefficients were statistically significant (Figure 2-2). Interestingly, for females, a peak in the 
population rate of decline in TL was observed in the age categories of 20-29 years (β=-0.0283, 
95% CI: -0.0468, -0.0099) and 50-59 years (β=-0.0216, 95% CI: -0.0396, -0.0036). Although 
women in the age categories of 30-39 years and 60-69 years displayed a minimal reduction in 
TL, the estimates were not statistically significant (Figure 2-2).   
 
Figure 2-1. Telomere length by age and gender in NHANES 1999-2002: 
(a) Male (β= -0.0153; p-value <0.001), (b) Female (β= -0.0129; p-value <0.001). Estimates, 
obtained from linear regression with telomere length (kbps) as outcome and age (years) 
as predictor, are adjusted for ethnicity, allostatic load and comorbidity index. 
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Figure 2-2.  Decline in telomere length by gender, across age groups, NHANES 1999-2002.  
Y-axis represents slope from a linear regression with telomere length (kbps) as outcome and 
age (years) as predictor. X-axis represents the age bins for the slope reported in Y-axis. 
Regression coefficients adjusted for ethnicity, allostatic load, and comorbidity index. 
 
To explore the heterogeneity in the population rate of decline in TL among females, we 
conducted additional analyses for women’s reproductive history, particularly parity and 
menopause, since ages 20-29 and 50-59 years are common ages for parity and menopause, 
respectively. After controlling for ethnicity, education, PIR, and BMI, the number of live 
children a woman had was negatively associated with TL (β=-0.0318, 95% CI: -0.0510, -
0.0125). Further, compared to nulliparous women, decline in TL was noted for women with live 
births (Appendix C). Similarly, women’s menopausal status (β=-0.2875, 95% CI: -0.3517, -
0.2232), age at menopause  (β=-0.0077, 95% CI: -0.0130, -0.0023) as well as years passed since 
menopause (β=-0.0095, 95% CI: -0.0127, -0.0063) were inversely associated with TL. Further, 
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variation in slope of decline in TL with years passed since menopause was noted by women’s 
weight status (Appendix D).  
 Discussion  
Overall, TL significantly reduced with age, but this decline was modified by gender, chronic 
stress and comorbidities; those with chronic morbidities and chronic stress experienced greater 
decline. Gender stratified analysis was more interesting, showing a fairly consistent and 
statistically non-significant rate for males but a substantial decline in TL for females in the age 
categories 20-29 and 50-59 years. Female reproductive factors, i.e., parity and menopause, were 
associated with TL. 
Decline in TL with age is unanimously supported by the literature (Broer et al., 2014; Needham, 
et al., 2013). Heterogeneity in rate of decline in TL is suggested by a previous study from the 
Erasmus Rucphen Family data, which found a significant reduction in variance in TL from 
young adulthood to old age by using the TL of grandchildren as a proxy for participants’ TL at 
childhood (Broer, et al., 2014). For females, a significant decline in the adjusted population rate 
of decline in TL was noted in early (20-29) and midlife (50-59) years. In general, for females the 
20-29 and 50-59 age bands are periods of important hormonal changes, as these are the common 
ages for parity and menopause, respectively. Consistent with previous studies, we found a 
significant negative association between TL and parity, menopausal status, and age at menopause 
(Gray et al., 2014). The observed inverse relationship between TL and parity is supported by the 
life history theory, which postulates that the energy used during reproduction reduces the energy 
available for tissue maintenance because the total amount of energy available for mobilization by 
an organism is finite at any given time, and that poor tissue maintenance, in turn, leads to faster 
cellular degradation and aging (Jasienska, 2001). Biologically, ovarian tissue aging or 
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tumorigenesis may be caused by hyper- or hypo-activity of estrogen (Bayne et al., 2011). 
Therefore, telomere attrition rate should accelerate after menopause in response to a decrease in 
estrogen (Bayne, et al., 2011). In vitro, telomerase activity is upregulated by estrogen (Cha, 
Kwon, Seol, & Park, 2008; Misiti et al., 2000). Population-based studies also provide evidence 
that greater estrogen exposure, as measured by the use of hormone therapy (Lee, Im, Kim, Lee, 
& Shim, 2005), and longer duration of reproductive years (Lin et al., 2011), are related to 
significantly higher TL in postmenopausal women. Oxidative stress and proinflammatory 
cytokines have also been associated with telomere shortening (O'Donovan et al., 2009; Passos, 
Saretzki, & von Zglinicki, 2007); thus, antioxidants aid in the attenuation of telomere shortening 
(Serra, von Zglinicki, Lorenz, & Saretzki, 2003; von Zglinicki et al., 2000). Estrogen is known to 
have antioxidant properties (Aviv, 2002; Vasa, Breitschopf, Zeiher, & Dimmeler, 2000); thus, 
the conferred protective role may be due to its ability to lower oxidative stress and reduce 
inflammation (Stice, Lee, Pechenino, & Knowlton, 2009; Xing, Nozell, Chen, Hage, & Oparil, 
2009). 
This study found that one-unit increases in allostatic load were associated with 17.3% decreases 
in TL. However, the findings did not remain statistically significant after controlling for 
covariates. Regardless, there is biological plausibility linking allostatic load and comorbidities 
with TL. Further analyses stratified by allostatic load levels showed a greater decline in TL 
among those with higher allostatic load. The allostatic load model posits that repeated or 
inadequate physiological adaption to social and environmental stress over time results in 
dysregulation of cortisol (via dysfunction of the hypothalamic-pituitary-adrenal axis) and 
catecholamines (via the sympathetic nervous system), which may in turn result in dysfunction of 
the body’s cardiovascular, immune, and metabolic systems (McEwen & Seeman, 1999). 
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Therefore, it is likely that TL may serve as an important cellular-based indicator of systemic 
allostatic load. Additionally, since TL is strongly correlated with chronological age, the latter had 
a powerful confounding effect on most of our estimates which lost statistical significance when 
adjusted for age. 
The associations between TL and various morbidities such as diabetes (Sampson, et al., 2006), 
heart disease (Brouilette, et al., 2007; Haycock, et al., 2014; van der Harst, et al., 2007; 
Weischer, et al., 2012), hypertension (Yang, et al., 2009) cancer (Zhu, et al., 2016), and 
depression (Ridout, et al., 2016), as well as overall mortality (Needham, et al., 2015; Rode, et al., 
2015) have been established. In this study, one-unit increases in comorbidities, as measured by 
the CCI, were associated with 7.2% decreases in TL, although findings lost significance after 
adjusting for age. Further, analyses stratified by comorbidity levels showed a greater decline in 
TL among those with four or more comorbidities. It has been suggested that telomere shortening 
might contribute to various morbidities through pathways involving cellular senescence, chronic 
inflammation and endothelial dysfunction (Minamino et al., 2002; Rufer et al., 1999).  
Many of the covariates we selected were associated with TL. TL in our study was positively 
correlated with HDL cholesterol and inversely correlated with BMI and heart rate (Rehkopf, et 
al., 2016). The existing literature on race/ethnicity and TL is inconsistent (Needham, et al., 2013; 
Rewak et al., 2014). In our study, NH Black had higher allostatic load compared to NH White 
(OR=1.32, 95% CI= 1.13-1.53), after adjustment for age, gender, and PIR. Despite the higher 
allostatic load, in overall and stratified analysis by allostatic load status, NH Black had higher TL 
than NH White. Although unexpected given that African-Americans experience greater stress in 
various life domains, sociocultural factors, such as social support and religion/spirituality, may 
enhance resilience when dealing with psychological distress for this group (McCreary, 
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Cunningham, Ingram, & Fife, 2006). These factors may nurture coping efficacy, which fosters an 
ability to manage adversity (McCreary, et al., 2006). More research is needed to understand 
relationships between high effort coping styles and TL for racial and ethnic populations in the 
US. Another surprising finding in our study was being unmarried was associated with longer TL 
than being married. This finding conflicts with other studies that showed being married is 
associated with longer TL (Mainous et al., 2011; Yen & Lung, 2013). In general, being 
unmarried is associated with poor health outcomes, presence of systemic inflammation 
(Engstrom, Hedblad, Rosvall, Janzon, & Lindgarde, 2006; Sbarra, 2009) increased mortality risk, 
and a shorter lifespan (Engstrom, et al., 2006; Molloy, Stamatakis, Randall, & Hamer, 2009; 
Sbarra, 2009; Scafato et al., 2008). Although the protective role of marriage is not completely 
understood, it has been hypothesized that the social, emotional, and financial support provided 
by a spouse/partner acts as a buffer to life stressors (Michael, Berkman, Colditz, Holmes, & 
Kawachi, 2002). Even among laboratory animals, social isolation was related to increased 
oxidative stress (Zhuravliova et al., 2009), which is related to telomere attrition. In our stratified 
analyses, we found that age and gender played a role in the association between marital status 
and TL. Thus, different mediators and moderators may explain the inconsistency observed in the 
relationship between marital status and TL attrition, which should be explored in future research. 
  Strengths, limitations and implications 
The strengths of the study include a large, nationally representative sample, rigorous 
methodology and the comprehensive quality control procedures of NHANES. During data 
analyses, adjustments were made for sampling weight and design to reduce errors in estimation. 
Given the cross-sectional design of NHANES, no causal inferences should be made from this 
study. Limitations were also observed for the quantification of allostatic load and CCI. Currently 
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no gold standard measure exists to quantify allostatic load, and while our approach was similar to 
others (Chen, et al., 2014; Parente, et al., 2013), the extent to which the measures of allostatic 
load actually reflect the complex concept of “wear and tear” is uncertain, which may impact the 
accuracy of the measurement, and consequently, the quality of the evidence generated. Of the 17 
comorbidities used in the original CCI, we were unable to include the measures of hemiplegia 
and metastatic cancer due to unavailability of data on these conditions in NHANES 1999-2002. 
Some of the disease statuses used in calculating CCI were self-reported. Lastly, the possibility of 
residual confounding due to unmeasured covariates cannot be ruled out. 
If the findings from this current study could be replicated with longitudinal data, there may be 
several important implications. First, our findings imply that interventions aimed at preserving 
TL should be targeted at younger ages, not just at old age. The heterogeneity in decline in TL 
and absence of a linear pattern in the oldest age category (≥80 years) may also partially explain 
the lack of statistical association between TL and survival, as seen in some studies conducted 
among the elderly. For women, a trough in decline in TL with age was noted in early and midlife 
years. Although 20-29 and 50-59 years are common ages for first childbirth and menopause, 
respectively, the underlying cause of the decline in these age categories is still not clear and 
should be addressed by future research.  
 Conclusions  
We found shorter TL with increasing age; this decline was modified by gender, chronic stress 
and comorbidities. Females in their twenties and fifties and those with chronic morbidities and/or 
chronic stress experienced greater TL decline. Female reproductive factors, i.e., parity and 
menopause, were associated with TL. Given the cross-sectional design of our study, future 
research should attempt to replicate our findings, specifically those related to parity and 
 26 
 
menopause, in a longitudinal design. Females in their twenties and fifties are potential subgroups 
of interest for any interventions or programs aimed at preserving TL. 
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Chapter 3. Manuscript 2 
 
“Can Healthy Eating Preserve Telomere Length? Association of Telomere 
Length with Nutrients and Healthy Eating Index” 
 
 Abstract  
 Background 
Preservation of telomere length (TL), a biomarker of aging, is hypothesized as one pathway by 
which proper nutrition can delay or prevent the development of chronic disease. Recent evidence 
that nutrition may preserve TL is promising. Here we examined the potential of healthy eating 
patterns or individual macro- and micro-nutrients as potential factors related to the preservation 
or attenuation of TL in a large, nationally representative US sample.  
 Methods 
 Cross-sectional data from 6645 non-pregnant individuals, aged ≥ 20 years with a TL 
measurement available, were included from the National Health and Nutrition Examination 
Survey, years 1999-2002. Multivariate linear regression models using energy-adjusted nutrients 
were used to quantify the associations between TL and individual macro- and micronutrients, 
and a Healthy Eating Index (HEI).  
 Results 
Of the macronutrients examined, total fat (β= -83.24, 95% CI: -153.31, -13.17), mono-
unsaturated (β= -107.40, 95% CI: -175.39, -39.40) and poly-unsaturated fatty acids (β=-54.01, 
95% CI: -99.81, -8.19) were inversely associated with TL. Of the micronutrients examined, 
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potassium was the only element (β= 90.17, 95% CI: 7.54, 172.79) and riboflavin, or Vitamin B2, 
(β= 85.04, 95% CI: 1.53, 168.54) was the only vitamin that was significantly associated with TL 
in fully adjusted models, although Vitamins A, B12, and E were inversely associated with TL in 
energy-adjusted models. After adjustment for total calorie, demographic factors, and health-
related behaviors, the overall HEI score was positively associated with TL (β= 3.42, 95% CI: 
0.29, 6.53, p-value=0.033); every unit increase in HEI score increased the TL by 3.42 base pairs. 
 Conclusions 
Our findings suggest that certain nutrients and healthy eating in general, easily achievable 
through adequate and healthy diets, are associated with preservation of TL.  
 Keywords  
Telomere Length, NHANES, Nutrients, Healthy Eating 
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 Introduction  
Telomere length (TL) attrition has been proposed as a primary hallmark of biological aging 
(Lopez-Otin, Blasco, Partridge, Serrano, & Kroemer, 2013) (Butler, et al., 2004; Guralnik, 2008; 
von Zglinicki & Martin-Ruiz, 2005). Telomeres, nucleoprotein structures located at the ends of 
eukaryotic chromosomes, protect the ends of the chromosome from degradation and end-to-end 
fusion (Blackburn, et al., 2006); therefore, they are also known as the chromosome’s protective 
cap. With each somatic cell division, there is a gradual attrition of the telomere, resulting in TL 
shortening with increasing age (Slagboom, et al., 1994). Hence, longer TL is an indicator of 
healthy aging (Cherkas, et al., 2008). Furthermore, a shorter TL is associated with disease 
(Haycock, et al., 2014; Sampson, et al., 2006) and death (Needham, et al., 2015). Independent of 
chronological age, there is substantial variation in the rate of telomere shortening (Ghimire, Hill, 
Sy, & Rodriguez, 2019), which suggests that telomere attrition may be a modifiable factor (Aviv, 
2006). Indeed, many population-based studies have provided evidence supporting the link 
between various lifestyle and behavioral risk factors and TL, suggesting that TL can be 
preserved (Aviv et al., 2009; Shammas, 2011). 
Eating a suboptimal diet is related to many health problems such as obesity, diabetes, 
cardiovascular diseases (CVD), and diet-related cancers (Danaei et al., 2009; Murray et al., 
2013). In the US, 650,000 deaths per year and 14% of all disability-adjusted life-years are 
attributed to dietary factors (Murray, et al., 2013). Preservation of TL may be one of the several 
pathways by which good nutrition can delay or prevent the development of chronic disease. 
Studies have provided evidence of preservation of TL with good nutrition (Freitas-Simoes, Ros, 
& Sala-Vila, 2016). Dietary antioxidants (Sen et al., 2014), Mediterranean diet (Boccardi et al., 
2013; Marin et al., 2012), Omega-3 fatty acids (Farzaneh-Far, Lin, Epel, Harris, et al., 2010), 
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seeds or derived products such as legumes and nuts (Lee, Jun, Yoon, Shin, & Baik, 2015) may 
help to preserve TL. In contrast, total and saturated fat intake (Cassidy et al., 2010; Tiainen et al., 
2012) and consumption of refined flour cereals (Cassidy, et al., 2010), meat and meat products 
(Nettleton, Diez-Roux, Jenny, Fitzpatrick, & Jacobs, 2008), and sugar-sweetened beverages 
(Leung et al., 2014) may shorten TL. A recent review revealed that evidence on the relationships 
between TL and fruits, vegetables, alcohol and dairy products is less robust (Freitas-Simoes, et 
al., 2016). Despite some evidence, the research on nutrition and TL is still in its infancy. Given 
that improved nutrition is an achievable and relatively inexpensive public health intervention 
compared to intensive medical interventions, it is important to confirm the counteracting role of 
improved nutrition in telomere epidemiology and the biological aging process. Prior 
investigations have focused on the link between TL and a limited number of nutrient 
components, but a comprehensive assessment of a wide range of micronutrients and 
macronutrients, including both total intake and intake within the context of dietary 
recommendations, has not yet been undertaken.  
The primary aim of our study is to examine the cross-sectional associations between 
micronutrients and macronutrients that may attenuate or preserve TL attrition in a large, US 
nationally representative sample. Additionally, we also examined the association of TL with each 
of the nutrients’ recommended daily intake and with the overall Healthy Eating Index (HEI). 
 Methods 
 Study design 
The National Health and Nutrition Examination Survey (NHANES) is a cross-sectional survey of 
nationally representative U.S. civilian noninstitutionalized population, conducted using a 
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complex, multistage, stratified, clustered sampling (Johnson, et al., 2013b). The details of 
NHANES data have been reported elsewhere (Johnson, et al., 2013b). We used data from the 
cycles 1999–2000 and 2001-2002 and combined them following the National Center for Health 
Statistics (NCHS) recommendations (Johnson, et al., 2013b). NHANES 1999-2001 oversamples 
Mexican Americans, non-Hispanic blacks, pregnant females, and adolescents 12-19 years of age, 
and adults > 60 years.  
 Study participants 
NHANES 1999-2000 and 2001-2002 included a total of 9,282 and 10,477 participants, 
respectively, in the mobile examination. Of these, 18,613 participated in the dietary interview but 
only 7,504, aged 20 and above, were eligible to provide DNA. Given that pregnant women have 
different nutritional requirements and survival bias is a potential issue among the extremely old, 
we excluded pregnant women (n= 446) and older adults 85 years and older (n= 199) and those 
with extreme total energy intake values (<600 or >5000 kcal/d) (n=214). For our analyses, we 
used data from a total of 6645 individuals, aged 20 to 84 years, from both NHANES 1999–2002 
cycles.  
 Ethical approval 
The study procedure of NHANES was approved by the NCHS Research Ethics Review Board. 
All participants provided written informed consent. Institutional Review Board at University of 
Nevada Las Vegas determined exempt status for this study.   
 Data collection  
Data collection in NHANES 1999–2002 was accomplished by NCHS-trained professionals 
through a computer-assisted in-person interview (CAPI), followed by assessments at a mobile 
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examination center (MEC) for a subset of participants. Data on participants’ demographics, self-
reported medical conditions, and behavioral factors were collect by CAPI; extensive physical 
examinations, blood and urine collection for laboratory measures were performed in the MEC 
(Johnson, Dohrmann, Burt, & Mohadjer, 2014). 
 Measurements 
3.3.5.1 Telomere length  
Leucocyte TL was measured from whole blood using the quantitative polymerase chain reaction 
method, described in detail elsewhere (Cawthon, 2002; Needham, et al., 2013). The mean and 
standard deviation of the T/S ratio (i.e., TL about standard reference DNA) are provided in the 
public dataset of NHANES. The lab conducting the DNA assay was blinded to all other 
measurements in the NHANES. Before releasing the public data of TL, a quality control review 
was conducted (CDC, 2010). During data analysis, T/S ratio was converted to kilobase-pairs 
(kbp) using the formula: (3,274 + 2,413 * (T/S))/1000 (Farzaneh-Far, Lin, Epel, Lapham, et al., 
2010).  
3.3.5.2 Dietary assessment in NHANES 
Participant’s total nutrient intakes was assessed by trained interviewers via in-person 24-hour 
dietary recalls (Blanton, Moshfegh, Baer, & Kretsch, 2006; Moshfegh et al., 2008) whereby 
detailed descriptions of all food and quantities eaten by an individual were recorded; description 
of the dietary interview methods is provided in the NHANES Dietary Interviewer's Training 
Manual (Blanton, et al., 2006; CDC, 2014). The details of all the macro- and micro-nutrients 
assessed in this study, with their measurement unit, are listed in Appendix E. Briefly, seven 
macronutrients (carbohydrate, protein, dietary fiber, total fat, total saturated fatty acids, total 
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mono- and poly-unsaturated fatty acids), nine elements (calcium, copper, iron, magnesium, 
phosphorus, selenium, zinc, potassium, sodium) and  ten vitamins (Vitamins A, B1, B2, B3, B6, 
B12, C, E, K and folate) were assessed. Furthermore, to calculate nutrient intake within the 
context of dietary recommendations, the proportion of participants meeting the recommended 
age- and sex-specific daily intake were calculated, using the 2005 Dietary Guidelines for 
Americans and Dietary Reference Intakes recommendations (Appendix E). 
3.3.5.3 Healthy Eating Index  
The HEI is a diet quality index that measures conformance to federal Dietary Guidelines for 
Americans (Guenther et al., 2013). Used to monitor the quality of American diets, it is the basis 
of nutrition policy for the US government and the foundation of all federal nutrition guidelines. 
The components of the HEI were calculated using NHANES dietary data and dietary weights 
from day 1, as described elsewhere (Basiotis, et al., 2002). Briefly, the HEI score is the sum of 
10 components (listed in Appendix F), each representing different aspects of a healthful diet. 
Components 1-5 measure the degree to which a person’s diet conforms to serving size 
recommendations for the five major food groups of the Food Guide Pyramid: grains, vegetables, 
fruits, milk, and meat. Components 6 and 7 measure total fat and saturated fat consumption, 
respectively, as a percentage of total food energy (calorie) intake. Components 8 and 9 measure 
total cholesterol intake and total sodium, and component 10 examines variety in a person’s diet. 
Each of these 10 components have a score ranging from 0-10; thus the HEI index ranges from 0-
100. High component scores indicate intakes close to the recommendation; low component 
scores indicate less compliance with recommended ranges or amounts. The mean HEI score for 
the US population  was 63.8 in 1999-2000  (Basiotis, et al., 2002) and 53.5 in 2007–2008 based 
on NHANES data (Guenther, et al., 2013).  
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3.3.5.4 Other covariates 
Covariates for this study, selected based on findings from previous literature, were  age 
(Mirabello et al., 2009), gender (Gardner, et al., 2014), race/ethnicity (Diez Roux et al., 2009; 
Hamad, Tuljapurkar, & Rehkopf, 2016; Hunt et al., 2008; Rewak, et al., 2014), educational 
attainment (Needham, et al., 2013), socioeconomic status (SES) (Cherkas, et al., 2008; 
Robertson et al., 2013), smoking (Cherkas, et al., 2008; Needham, et al., 2013), alcohol 
consumption (Pavanello et al., 2011), physical activity levels (Ludlow et al., 2008; Savela et al., 
2013), sedentary lifestyle (Cherkas, et al., 2008; Du et al., 2012), and body mass index (BMI) 
(Kim et al., 2009; Valdes et al., 2005).  
Age, sex, race/ethnicity (Hispanic, non-Hispanic [NH] white, NH Black, and others including 
multi-racial); educational level (<12th grade, high school graduate/some college and college 
graduate or above), and marital status (married/living with partner, divorced/widowed/separated, 
and never married) were self-reported by the participants. SES was measured in terms of poverty 
income ratio (PIR), the ratio of family income to the poverty threshold, calculated following the 
U.S. Department of Health and Human Services’ poverty guidelines (HHS, 2013) and described 
in detail elsewhere (Johnson et al., 2013a). In short, PIR was calculated by dividing family 
income by the poverty guidelines specific to family size, as well as the appropriate year and state 
(Johnson, et al., 2013a). BMI, the ratio of weight/height2 measured in kg/m2, was available as a 
continuous measure.  
We categorized smoking into every day, some days, not at all. Alcohol intake was assessed by 
lifetime and current alcohol use and classified into three categories: abstainers, 
occasional/moderate drinkers, and heavy drinkers, based on the Dietary Guidelines for 
Americans, 2005 (HHS, 2005) that recommend a sex-specific cut point of one drink or fewer per 
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day for women and two drinks or fewer per day for men. Respondents who consumed alcohol 
more than the recommended levels were considered heavy drinkers; otherwise, they were 
classified as occasional/moderate drinkers. Those reporting no alcohol consumption ever were 
considered abstainers. Physical activity was categorized into inactive (no physical activity), 
moderate (self-reported participation, over the past 30 days, in moderate activities such as brisk 
walking, bicycling for pleasure, golf and dancing that cause only light sweating or a slight to 
moderate increase in breathing or heart rate) and vigorous (self-reported participation, over the 
past 30 days, in vigorous activities such as brisk walking, bicycling for pleasure, golf and 
dancing that caused heavy sweating or large increases in breathing or heart rate). Participants 
were also classified in terms of their health outcomes. Participants were considered morbid if 
they had at least one of the following chronic conditions: diabetes, CVD, cancer, kidney disease, 
or liver disease (Detailed definitions provided in Appendix G). 
 Statistical analyses 
Sample weights, the four-year dietary weight, were used to adjust data according to NHANES 
guidelines to generate a nationally representative sample (Johnson, et al., 2013b). Percentages 
with 95% CIs and unadjusted means with standard error (SEM) are provided for nominal and 
continuous variables, respectively (Table 3-1). Differences in covariate characteristics between 
the quartiles of TL were compared using Rao-Scott Chi-Square test and analysis of variance 
(ANOVA). The normality of continuous variables was assessed; non-normal variables were 
subsequently log–transformed. The associations between TL and different nutrients and HEI 
were quantified in multivariable linear regression models. For all regression analyses, TL was 
expressed in the unit of base pairs. Intake of all dietary components was energy-adjusted using 
the residual method whereby energy-adjusted nutrient intakes are computed as the residuals from 
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a regression model with total energy intake as the independent variable and absolute nutrient 
intake as the dependent variable; this adjustment minimizes measurement error in dietary 
estimates (Willett, 2013). Model 1 provides the energy-adjusted coefficient. Model 2 is adjusted 
for demographic variables (i.e., age, gender, race/ethnicity, marital status, education, socio-
economic status, BMI, smoking, alcohol use, and physical activity), shown to be predictors of 
TL in this study population by a previous study (Needham, et al., 2013). Since TL is strongly 
correlated with chronological age, the latter had a potential for nonlinearity and a powerful 
confounding effect on the estimates in previous studies (Ghimire, et al., 2019; Rehkopf et al., 
2013). Thus, we used age both as a continuous linear and as an age-squared measure. 
Additionally, in subgroup analyses, we examined the effect measure modification of our 
observed estimates by age groups (20–44, 45-64, and 65–85) and by gender.  
We also performed a sensitivity analysis, restricting the population to individuals who did not 
use a multi-vitamin supplement and had chronic disease conditions. In the sensitivity analysis, 
we replaced the continuous level of nutrient intake with meeting the daily recommended 
threshold measures (binary, yes/no). A 2-tailed p-value less than 0.05 was considered statistically 
significant. The survey procedures in SAS 9.4 (SAS Institute Inc., Cary, NC) was used for data 
analysis. 
 Results  
 Characteristics of participants 
Table 3-1 shows the demographic characteristics of the study participants by quartiles of TL. The 
mean (±SEM) TL of the participants was 5.8±0.04 kbp (Table 3-1). In bivariate analyses, 
participants with shorter TL, i.e., in lower quartiles, were older, male, NH White, with less than 
 37 
 
high school education, married, and had higher BMI and at least one morbid condition (Table 
3-1).  
The mean intakes of total energy, various macro- and micro-nutrients are presented in Appendix 
H. Although the mean intakes of energy, various macro- nutrients, elements and vitamins, except 
Vitamin A, E, and K, significantly differed between the quartiles of TL, no clear trend was noted 
(Appendix H). 
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Table 3-1. Socio-demographic characteristics of the study participants by quartiles of telomere length- NHANES 1999-2002 
  Overall  
(N= 6645) 
Quartiles 1 
(N=1917) 
Quartiles 2 
(N=1703) 
Quartiles 3 
(N=1625) 
Quartiles 4 
(N=1400) 
  
p-Value 
  N % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) 
Age, Mean ± SEM  6645 46.4 ± 0.3 55.6 ± 0.7 48.1 ± 0.8 43.1 ± 0.7 38.5 ± 0.8 <0.001 a 
Telomere length (Kbp), Mean 
± SEM 
6645  5.8 ± 0.0  5.1 ± 0.0  5.6 ± 0.0  5.9 ± 0.0  6.7 ± 0.0 <0.001 a 
Gender               
 Male 3393 49.5 (48.1-50.9) 51.4 (48.0-54.9) 48.9 (45.9-51.8) 47.8 (45.1-50.5) 49.9 (47.3-52.5) 0.3111 
 Female 3252 50.5 (49.1-51.9) 48.6 (45.1-52.0) 51.1 (48.2-54.1) 52.2 (49.5-54.9) 50.1 (47.5-52.7)   
Race/Ethnicity               
 Hispanic 1954 13.0 (9.4-16.6) 11.1 (6.1-16.2) 12.8 (8.9-16.7) 14.0 (9.5-18.4) 14.3 (10.1-18.5) 0.0185 
 NH White 3378 74.1 (70.6-77.5) 78.1 (73.4-82.9) 75.9 (71.9-79.9) 72.0 (67.1-77.0) 70.2 (65.1-75.2)   
 NH Black 1128  9.0 (6.9-11.1)  7.0 (5.0-8.9)  8.3 (5.8-10.7)  8.8 (6.8-10.9) 12.0 (8.4-15.5)   
Other 185  3.9 (2.7-5.1)  3.8 (1.7-5.9)  3.0 (1.8-4.2)  5.2 (3.4-7.0)  3.6 (1.5-5.8)   
Educational Status               
 <12th Grade 2198 20.4 (18.5-22.3) 25.1 (22.2-28.1) 20.2 (17.6-22.8) 19.7 (16.5-22.9) 16.5 (14.0-19.1) 0.005 
High School/Some College 3206 54.6 (51.8-57.4) 53.7 (49.5-57.8) 55.5 (51.4-59.5) 53.4 (49.2-57.6) 55.9 (50.3-61.5)   
 College Graduate 1234 25.0 (21.8-28.2) 21.2 (17.0-25.4) 24.4 (20.5-28.2) 26.9 (21.9-32.0) 27.6 (21.9-33.4)   
Marital Status               
 Married or Living with Partner 4079 65.3 (63.2-67.4) 70.0 (67.4-72.6) 66.5 (63.1-69.9) 63.0 (59.4-66.6) 61.4 (57.4-65.5) <0.001 
 Divorced/Widowed/Separated 1300 18.0 (16.6-19.4) 22.0 (19.7-24.3) 20.5 (18.1-22.9) 16.6 (13.5-19.7) 12.5 (9.8-15.1)   
 Never Married 949 16.7 (14.8-18.6)  8.0 (6.3-9.7) 13.0 (10.1-15.9) 20.4 (17.6-23.3) 26.1 (22.7-29.6)   
Socio-economic Status               
 Below official poverty threshold 1035 13.5 (11.9-15.2) 12.6 (10.3-14.9) 12.1 (9.6-14.6) 13.8 (11.3-16.4) 15.6 (12.3-18.9) 0.1545 
 Above official poverty threshold 5030 86.5 (84.8-88.1) 87.4 (85.1-89.7) 87.9 (85.4-90.4) 86.2 (83.6-88.7) 84.4 (81.1-87.7)   
Body Mass Index, Mean ± SEM 6508 28.1 ± 0.2 28.7 ± 0.2 28.3 ± 0.3 27.9 ± 0.3 27.3 ± 0.2 <0.001 a 
Smoking               
 Every day 1231 40.6 (37.6-43.6) 36.9 (32.0-41.8) 40.2 (33.4-47.1) 43.3 (38.2-48.4) 42.8 (37.3-48.2) <0.001 
 Some days 264  8.0 (6.4-9.5)  4.6 (2.8-6.4)  5.1 (3.3-6.9)  7.5 (5.2-9.8) 15.7 (11.2-20.2)   
 Not at all 1805 51.4 (48.4-54.4) 58.5 (53.9-63.2) 54.7 (47.6-61.8) 49.2 (44.2-54.2) 41.6 (35.3-47.8)   
Alcohol use               
 Nondrinker/abstainers 896 14.3 (10.0-18.6) 15.1 (11.7-18.5) 13.3 (9.2-17.5) 15.4 (9.3-21.5) 13.3 (7.8-18.9) <0.001 
 Moderate/occasional drinker 2741 47.2 (44.2-50.1) 54.9 (51.2-58.5) 49.9 (46.0-53.8) 42.9 (37.4-48.4) 41.4 (37.2-45.6)   
 Heavy drinker 2072 38.5 (35.5-41.6) 30.1 (26.7-33.4) 36.7 (32.2-41.3) 41.7 (37.1-46.3) 45.2 (40.1-50.4)   
Physical Activity               
  Physically active 3981 68.4 (66.0-70.8) 61.4 (58.1-64.6) 67.1 (63.5-70.6) 70.9 (67.5-74.4) 74.3 (70.4-78.2) <0.001 
  Physically inactive 2662 31.6 (29.2-34.0) 38.6 (35.4-41.9) 32.9 (29.4-36.5) 29.1 (25.6-32.5) 25.7 (21.8-29.6)   
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At least one morbid condition 2231 28.8 (26.9-30.7) 41.3 (38.0-44.6) 29.6 (26.4-32.8) 25.6 (21.9-29.3) 18.6 (15.9-21.3) <0.001 
Cardiovascular disease 697  8.5 (7.6-9.5) 15.3 (13.1-17.4)  9.6 (7.2-12.1)  5.7 (4.1-7.2)  3.5 (2.3-4.7) <0.001 
Diabetes 882  9.4 (8.4-10.4) 14.1 (12.5-15.7) 10.5 (8.4-12.5)  7.4 (5.3-9.5)  5.6 (4.3-6.9) <0.001 
Cancer 552  8.3 (7.2-9.4) 13.1 (10.5-15.7)  7.8 (5.9-9.8)  7.2 (5.4-8.9)  5.0 (3.4-6.6) <0.001 
Kidney disease 826  9.7 (8.6-10.8) 12.7 (10.4-14.9)  9.4 (7.7-11.0)  9.0 (6.7-11.2)  7.6 (5.2-10.1) 0.0046 
Liver disease 214  3.3 (2.5-4.1)  3.8 (2.7-4.9)  3.9 (2.3-5.5)  2.4 (1.2-3.6)  3.0 (1.8-4.1) 0.2266 
a: p-values from one-way ANOVA; all others from a Chi-square test. Abbreviation: CI: confidence interval, Kbp: kilo base pairs, NH: Non-Hispanic, SEM: standard error of mean. 
Values expressed are % (95% CI) unless otherwise stated. 
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 Association between telomere length and nutrients  
3.4.2.1 Macronutrients 
Among the macronutrients examined (listed in Table 3-2), total fat, saturated and unsaturated 
fatty acids were inversely associated with TL. In the model adjusted for total energy intake, 
demographic and health-related behaviors, an increase in one gram of total fat intake was 
associated with a decrease in 83.24 base pairs of TL (Table 3-2). However, in subgroup analyses 
by gender (Appendix I), the inverse association between fat intake and TL was significant only 
for females. Further, statistical significance was lost in sensitivity analyses limited to healthy 
participants and those not taking any dietary supplements (Appendix J). 
3.4.2.2 Micronutrients 
We evaluated the relationship between TL and nine different elements and ten different vitamins 
(listed in Table 3-2). Of the elements, only potassium was significantly associated with TL, in 
both energy-adjusted and fully-adjusted models. In the model adjusted for total energy intake, 
demographic and health-related behaviors, an increase in one gram of potassium increased the 
TL by 90.17 base pairs (Table 3-2). No effect modification by age and sex was observed in 
subgroup analyses (Appendix I). Moreover, of the vitamins examined, Vitamins A, B2 
(riboflavin), B12, and E were inversely associated with TL in energy adjusted models (Table 
3-2). However, statistical significance was lost for all vitamins except for riboflavin, in the fully 
adjusted models (Table 3-2). In sub-group analyses, riboflavin was significantly positively 
associated with TL among males (Appendix I).
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Table 3-2. Multivariable regression for macro- and micro-nutrients associated with telomere length (base pairs) - NHANES 
1999-2002 
Total nutrients intake Model 1– energy adjusted Model 2– energy + demographic + health-
related behaviors adjusted 
β 95% CI p-value β 95% CI p-value 
Macronutrients       
Carbohydrate (gm) 103.83 -6.64, 214.29 0.064 105.99 13.42, 198.55 0.026 
Protein (gm) -27.38 -81.53, 26.77 0.310 27.87 -57.56, 113.30 0.510 
Dietary fiber (gm) -63.96 -116.51, -11.40 0.019 -3.17 -61.02, 54.69 0.912 
Total fat (gm) -144.64 -218.03, -71.24 0.000 -83.24 -153.31, -13.17 0.022 
Total saturated fatty acids (gm) -70.34 -116.28, -24.39 0.004 -53.39 -122.58, 15.80 0.125 
Total monounsaturated fatty acids (gm) -121.21 -181.77, -60.65 0.000 -107.40 -175.39, -39.40 0.003 
Total polyunsaturated fatty acids (gm) -89.41 -139.09, -39.73 0.001 -54.01 -99.81, -8.19 0.023 
Elements       
Calcium (mg) -12.63 -55.90, 30.64 0.555 15.50 -56.12, 87.12 0.661 
Copper (µg) -38.48 -98.95, 21.98 0.203 54.09 -29.32, 137.50 0.195 
Iron (mg) -41.38 -115.96, 33.19 0.266 31.23 -55.31, 117.77 0.466 
Magnesium (mg) -73.66 -157.36, 10.05 0.082 59.55 -47.99, 167.09 0.267 
Phosphorus (mg) -55.68 -121.10, 9.73 0.092 13.31 -93.96, 120.58 0.801 
Selenium (µg) -42.11 -98.74, 14.51 0.139 -11.53 -87.83, 64.77 0.760 
Zinc (mg) -30.05 -73.78, 13.68 0.171 49.73 -20.72, 120.17 0.160 
Potassium (g) -129.00 -202.07, -55.92 0.001 90.17 7.54, 172.79 0.034 
Sodium (g) -53.20 -122.14, 15.73 0.125 -18.18 -117.47, 81.12 0.711 
Vitamins       
Vitamin A (µg) -54.01 -100.24, -7.77 0.024 -9.84 -64.95, 45.27 0.718 
Thiamin (Vitamin B1) (mg) -11.76 -58.86, 35.33 0.613 58.35 -12.57, 129.27 0.103 
Riboflavin (Vitamin B2) (mg) -64.49 -126.81, -2.17 0.043 85.04 1.53, 168.54 0.046 
Niacin (Vitamin B3) (mg) -32.09 -90.91, 26.72 0.274 -19.40 -96.78, 57.98 0.612 
Vitamin B6 (mg) -17.57 -71.17, 36.03 0.508 56.29 -14.91, 127.50 0.117 
Vitamin B12 (µg) -30.34 -56.40, -4.27 0.024 17.80 -28.96, 64.55 0.443 
Folate (µg) 2.31 -57.45, 62.08 0.938 35.86 -46.22, 117.94 0.379 
Vitamin C (mg) -2.91 -34.83, 29.00 0.853 18.51 -13.83, 50.85 0.251 
Vitamin E (mg) -78.93 -139.29, -18.55 0.012 -44.37 -101.22, 12.47 0.121 
Vitamin K (µg) -20.22 -49.68, 9.24 0.171 19.80 -25.55, 65.15 0.379 
Model 1– energy adjusted, Model 2– energy, age, age-squared, sex, race/ethnicity, marital status, education, socio-economic status, BMI, 
smoking, alcohol use, and physical activity adjusted. 
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 Association between telomere length and recommended daily intakes of nutrients  
In an unadjusted model (Table 3-3), compared to participants who met the recommended daily 
intakes for a given element, participants not meeting the recommended daily intakes of calcium, 
magnesium, phosphorus, and zinc were more likely to have shorter telomeres. However, the 
findings were not statistically significant when adjusted for covariates.  Likewise, for vitamins, 
participants who did not meet the daily intake of Vitamin B3 and Vitamin B6 had shorter TL by 
83 and 134 base pairs, respectively, compared to those who met the recommendation for each 
given vitamin. However, statistical significance was again lost in the adjusted model (Table 3-3).  
 
 Association between telomere length and Healthy Eating Index  
Appendix K shows the association between telomere length and each of the ten components of 
the HEI.  After adjustment for total calorie, demographic, and health-related behaviors, the 
overall HEI score was positively associated with TL (β= 3.42, 95% CI: 0.29, 6.53, p-
value=0.033); every unit increase in HEI score increased TL by 3.42 base pairs. 
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Table 3-3. Multivariable regression for recommended daily intakes of nutrients associated 
with telomere length- NHANES 1999-2002 
 
 Model 1–unadjusted 1Model 2– demographic + 
health-related behaviors 
adjusted 
β 95% CI p-
value 
β 95% CI p-
value 
Macronutrients Reference = Meeting the recommended daily intakes for respective 
nutrients 
Carbohydrate (gm) -92.91 -209.35, 23.54 0.114 -41.61 -198.93, 115.70 0.593 
Protein (gm) -67.64 -137.56, 2.28 0.057 -10.56 -93.26, 72.14 0.796 
Dietary fiber (gm) -29.5 -165.51, 106.52 0.661 136.86 5.08, 268.65 0.042 
Elements       
Calcium (mg) -153.07 -226.90, -79.24 <0.001 -35.31 -175.66, 105.04 0.611 
Copper (µg) -54.85 -133.83, 24.12 0.166 -64.28 -174.82, 46.27 0.244 
Iron (mg) 152.05 60.32, 243.78 0.002 51.39 -67.16, 169.94 0.383 
Magnesium (mg) -120.71 -204.40, -37.01 0.006 24.24 -72.26, 120.74 0.611 
Phosphorus (mg) -84.86 -168.59, -1.14 0.047 -18 -108.41, 72.42 0.687 
Selenium (µg) -71.31 -161.95, 19.34 0.119 25.93 -96.71, 148.57 0.669 
Zinc (mg) -84.67 -142.39, -26.95 0.006 -1.39 -99.38, 96.59 0.977 
Potassium (g) -114.94 -264.99, 35.11 0.128 63.09 -166.91, 293.09 0.579 
Sodium (g) -25.82 -113.15, 61.50 0.550 93.32 -29.25, 215.89 0.130 
Vitamins       
Vitamin A (µg) -77.66 -164.48, 9.16 0.078 25.82 -105.37, 157.01 0.690 
Thiamin (Vitamin B1) (mg) -58.8 -125.70, 8.09 0.083 -26.52 -112.34, 59.31 0.532 
Riboflavin (Vitamin B2) 
(mg) 
-38.78 -131.82, 54.26 0.401 -
106.08 
-212.80, 0.63 0.051 
Niacin (Vitamin B3) (mg) -82.52 -151.04, -14.00 0.020 -21.47 -121.71, 78.78 0.665 
Vitamin B6 (mg) -134.57 -197.92, -71.23 <0.001 -82.06 -167.22, 3.10 0.058 
Vitamin B12 (µg) -28.7 -97.19, 39.80 0.399 31.01 -66.44, 128.45 0.520 
Folate (µg) -58.88 -143.98, 26.23 0.168 -34.74 -163.06, 93.58 0.584 
Vitamin C (mg) -50.67 -117.96, 16.62 0.134 -14.3 -80.18, 51.58 0.660 
Vitamin E (mg) -11.81 -137.09, 113.47 0.848 69.71 -109.00, 248.42 0.431 
Vitamin K (µg) -26.58 -87.47, 34.31 0.379 -10.96 -110.84, 88.92 0.824 
1Model 1– unadjusted, Model 2– Model 2– energy, age, age-squared, sex, race/ethnicity, marital status, 
education, socio-economic status, BMI, smoking, alcohol use, and physical activity adjusted.  
 
 
 Discussion 
In a large, nationally representative sample of Americans, this study aimed to comprehensively 
examine the cross-sectional associations between micronutrients and macronutrients that may 
attenuate or preserve TL attrition. An inverse association between TL and fat intake was found, 
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as well as a positive association between TL and two micronutrients: the mineral potassium and 
Vitamin riboflavin. Additionally, the overall HEI score was positively associated with TL.  
Among the various macro- and micro-nutrients examined in the current study, fat (total fat and 
unsaturated fatty acids) was the only macronutrient significantly associated with TL with an 
inverse relationship. This finding is consistent with previous studies (Cassidy, et al., 2010; 
Tiainen, et al., 2012), which suggests that reduction in fat intake may increase longevity. Given 
that the cardioprotective benefits offered by polyunsaturated fatty acids are well-established 
(Harris et al., 2009), the observed inverse association between unsaturated fatty acids and TL 
was particularly concerning. Our finding is consistent with a few previous studies (Cassidy, et 
al., 2010; Kiecolt-Glaser et al., 2013). However, others found positive or non-significant 
associations between TL and polyunsaturated fatty acids (Farzaneh-Far, Lin, Epel, Harris, et al., 
2010; Song et al., 2013). A randomized controlled trial, assessing the impact of n-3 
polyunsaturated fatty acid supplementation on leukocyte TL and telomerase, suggests that 
decreasing n-6:n-3 polyunsaturated fatty acids ratios increases TL (Kiecolt-Glaser, et al., 2013). 
The relationship between TL and polyunsaturated fatty acids warrants further investigation and 
clarification. Overall, previous findings regarding the association between TL and different 
nutrients, including those statistically non-significant in this study, are inconsistent and complex 
to summarize. Appendix L tabulates the literature on the association between TL and various 
nutrients. 
Among the micronutrients, only potassium and riboflavin were significantly positively 
associated with TL. (Sen, et al., 2014). Specific nutrients, such as folate (Moores, Fenech, & 
O'Callaghan, 2011), vitamins B, D, E, and C (Sen, et al., 2014) and zinc (Sharif, Thomas, 
Zalewski, & Fenech, 2012), provide the necessary building blocks to support telomere health; 
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thus, they are anticipated to preserve TL. However, previous research has shown mixed results. 
One cross-sectional study among 586 U.S. women who did not use multivitamin supplements 
reported a significant direct association of TL with vitamin A, vitamin C, vitamin E, folic acid, 
calcium, and magnesium but no association with vitamin B6, vitamin B12, vitamin D, selenium, 
iron, and zinc (Xu et al., 2009). In contrast, a cross-sectional study among 786 Austrian males 
found a significant direct associations with vitamin C but no association with vitamin A, vitamin 
E, and total antioxidant status. Other studies show similarly inconsistent results (Appendix L). 
Our finding that higher HEI scores were associated with longer TL is important. Previously, 
some dietary patterns, especially the Mediterranean and calorie-reduced diets, were positively 
linked to TL (Boccardi, et al., 2013; Freitas-Simoes, et al., 2016; Marin, et al., 2012). Moreover, 
previous studies using NHANES data also linked Mediterranean Diet scores and Dietary 
Approaches to Stop Hypertension (DASH) scores with longer telomere length in women (Leung, 
Fung, McEvoy, Lin, & Epel, 2018); the pro-inflammatory diet was significantly associated with 
shorter TL (Shivappa, Wirth, Hurley, & Hebert, 2017). It is possible that the synergistic effects 
of nutrients, usually consumed together, may explain the observed non-significance at individual 
nutrient level but positive associations with overall HEI score. Higher HEI scores, a snapshot of 
higher overall diet quality or intakes close to the recommended amounts, have been associated 
with lower risk of chronic diseases such as type 2 diabetes, CVD, cancer (Chiuve et al., 2012), 
and all-cause, CVD, and cancer mortality (Reedy et al., 2014). Thus, emphasis should probably 
be placed not on individual nutrients but rather the importance of overall healthy eating.  The 
mechanism linking higher diet quality and preservation of TL has not yet been delineated, but 
may be similar to the mechanism by which it reduces the risk of chronic disease and mortality: 
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by reducing oxidative stress, inflammation, and metabolic dysregulation (Sanders & Newman, 
2013; von Zglinicki & Martin-Ruiz, 2005).  
This study has some strengths and limitations. The strengths of the study include a large, 
nationally representative sample, rigorous methodology and the comprehensive quality control 
procedures of NHANES. During data analyses, adjustments were made for sampling weight and 
design to reduce errors in estimation. Given the cross-sectional design of NHANES, no causal 
inferences should be made from this study regarding the relationship between TL, nutrients and 
HEI. Limitations can also be seen in terms of participants’ self-reported dietary data. In general, 
self-reported dietary data are attenuated compared to their respective standard biomarker (Day, 
McKeown, Wong, Welch, & Bingham, 2001; Schatzkin et al., 2003). Nevertheless, self-reported 
24-hour recall is a convenient, inexpensive and widely-used method for estimating an 
individual’s dietary intake (Schatzkin, et al., 2003). Additionally, the 24-hour recall used in 
NHANES is a highly standardized version developed by the US Department of Agriculture for 
use in national dietary surveillance (Moshfegh, et al., 2008). Finally, our data are not recent; they 
date back to 1999–2002. However, the TL assays were done in 2011, following recent 
methodological approaches. Since the measure of TL varies with different cell types (Lin et al., 
2010), our findings may only be comparable to other studies assessing TL from leucocytes. 
Given that the majority of the literature on the relationship between nutrition and TL comes from 
cross-sectional designs, longitudinal studies are needed in the future to make valid causal 
inferences.  
 Conclusions  
In conclusion, this study suggests that certain micro-nutrients and overall healthy eating in 
general may be associated with preservation of TL whereas fat consumption may be associated 
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with attenuation of TL. Given that malnutrition is indisputably a prominent problem among the 
geriatric population (Lee & Frongillo, 2001; Pillsbury, Miller, Boon, & Pray, 2010) and that 
optimum nutrition is an easier to achieve and relatively inexpensive public health intervention 
compared to intensive medical interventions, the importance of healthy eating for overall health 
benefits, healthy aging, and preserving telomeres should be emphasized. Specifically, improving 
overall diet quality rather than emphasizing individual nutrients should be encouraged. 
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Chapter 4. Manuscript 3 
  
“Association between Telomere Length, Survival, and Lifespan among 
Elderly Men from the Zutphen and Crete Elderly Study” 
 
 Abstract  
 Background 
This study assesses the associations of telomere length (TL), a biomarker of aging, with risk 
factors, survival, and lifespan among the oldest old men from the Zutphen (The Netherlands) and 
Cretan (Greece) Elderly Study. 
 Methods 
 In Zutphen and Crete, 328 elderly men with available TL measurement, aged 79-98 years, were 
enrolled in 2000; follow-up for vital status was available until September 2015. TL 
measurements and risk factors were available for 144 men in Zutphen and 122 on Crete and 
included in the current analyses. Kaplan-Meier survival estimation assessed differences in 
survival between men with short and long TL. Univariate and multivariable Cox proportional 
hazard models assessed the associations of TL (standardized continuous measure) on survival. 
Linear regression models assessed the relation of TL on age at death.  
 Results 
All but nine men were deceased by the end of the study period. TL was not related to socio-
demographic factors, lifestyle factors, and prevalent chronic diseases. Kaplan-Meier survival 
analysis did not show statistically significant differences in all-cause or cardiovascular mortality 
between long and short TL groups. In Cox proportional hazards models, long TL was not 
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associated with all-cause (HR: 0.90, 95%CI: 0.68 - 1.17) and cardiovascular mortality (HR: 0.96, 
95%CI 0.62 - 1.50). In linear regression models, TL was not a significant predictor of age at 
death. Findings were also not significant when analyzed separately for the Zutphen and Cretan 
cohort.   
 Conclusions 
In this homogeneous, healthy and long surviving older adult population, TL was not associated 
with lifespan or mortality, which is consistent with previous literature suggesting survival effect; 
the known predictors of mortality do not demonstrate an association among long-surviving 
individuals.  
 Keywords 
Telomere length, Mortality, Lifespan, Zutphen, Crete, Elderly Men. 
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 Introduction 
Telomeres are nucleoprotein structures located at the ends of eukaryotic chromosomes, 
protecting the end of the chromosome from degradation and end-to-end fusion (Blackburn, et al., 
2006), and are thus also known as the chromosome’s protective cap. With each somatic cell 
division, there is a gradual attrition of the telomere, and thus their length shortens with increasing 
age (Muezzinler, Zaineddin, & Brenner, 2013). When telomeres reach a critical minimal length, 
the cell may enter apoptosis (Blackburn, 2000; Blasco, 2007). Telomere length (TL) has been 
proposed as a candidate biomarker of human aging (von Zglinicki & Martin-Ruiz, 2005), 
whereby longer TL is an indicator of healthy aging (Cherkas, et al., 2008). Telomere shortening 
has been linked to oxidative stress, inflammation, and metabolic dysregulation (Sanders & 
Newman, 2013; von Zglinicki & Martin-Ruiz, 2005). 
Over a decade has passed since the early reports of an inverse association between TL and 
mortality (all-cause, heart, and infectious disease mortality) (Cawthon, Smith, O'Brien, 
Sivatchenko, & Kerber, 2003). Since then, many studies looking at the association between TL 
and mortality have been conducted, but findings are inconsistent over the lifespan. Most studies 
have provided evidence that short TL is associated with increased mortality (Astrup et al., 2010; 
Bakaysa et al., 2007; Cawthon, et al., 2003; Epel et al., 2008; Farzaneh-Far et al., 2008; 
Fitzpatrick et al., 2007; Kimura et al., 2008; Martin-Ruiz et al., 2006; Needham, et al., 2015), 
whereas other studies did not show an association between TL and all-cause mortality (Bendix et 
al., 2014; Bischoff et al., 2006; Fitzpatrick, et al., 2007; Harris et al., 2006; Houben, Giltay, 
Rius-Ottenheim, Hageman, & Kromhout, 2011; Martin-Ruiz, Gussekloo, van Heemst, von 
Zglinicki, & Westendorp, 2005; Njajou et al., 2009; Strandberg et al., 2011; Zekry et al., 2012). 
The link between TL and mortality is an ongoing area of research.  
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Previously, using data from  the Zutphen Elderly Study, it was reported that TL was not 
predictive of all-cause mortality, cardiovascular mortality, or cancer mortality among elderly 
men in Zutphen (Houben, et al., 2011). The current study is an update to the previously 
published study (Houben, et al., 2011). However, the relevance of the current study is multi-fold.  
First, the mortality data in the Zutphen Elderly Study (the Netherlands) has been updated through 
2015; the former analyses had a follow-up of 7 years from 1993 until 2000. So, it would be 
worth updating the previous study in old men (Houben, et al., 2011). Second, in the current 
study, data were included from the Cretan Elderly Study (Greece). Since elderly men from Crete 
are thought to have, on average, healthier lifestyles than the Northern European Zutphen men 
due to the Mediterranean diet, physical activity and longer survival, it would be interesting to 
investigate the differences in survival between the elderly men from two different European 
countries, in terms of TL (Keys et al., 1980; Kromhout et al., 1989; Menotti et al., 2001). Finally, 
in addition to linking TL to all-cause mortality, we also assessed TL in relation to age at death or 
the lifespan. Therefore, this study assessed the association of TL with mortality and lifespan 
among elderly men from Zutphen and Crete. 
 Methods 
 Study population 
The Zutphen Elderly Study (the Netherlands) and the Cretan Elderly Study (Greece) are  
components of the Seven Countries Study (Buijsse et al., 2007), a longitudinal study to 
investigate dietary and other risk factors for chronic diseases. The details of the Zutphen Elderly 
Study and the Cretan Elderly Study are provided elsewhere (Buijsse, et al., 2007; Houben, et al., 
2011). Briefly, The Zutphen Elderly Study consisted of 887 men, born between 1900 and 1920, 
in 1985 were followed over time, every five years between 1985 and 2000, as well as in 1993. In 
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the follow-up examination in 2000, 240 men aged 80–98 were still alive, of whom 176 men were 
enrolled in the study and 144 men had TL measurements. The Cretan sample in 2000 consisted 
of 165 men, aged 79–96 years, of whom 152 consented to participate, and 122 men had TL 
measurements. Thus, information on 144 men from Zutphen cohort and 122 from Cretan cohort 
were used for the present study. The survey took place in Crete between May and August 2000, 
and in Zutphen between March and June 2000. 
Although TL in the Zutphen Elderly Study was available for 203 men in 1993, of whom 75 men 
had TL assessed both in 1993 and in 2000, we limited our analysis to the ‘baseline’ year 2000 
because TL was measured for the Cretan sample only in 2000, and not in 1993. Furthermore, a 
previous study on 7 year mortality has already been published that included the Zutphen 
participants from 1993 (Houben, et al., 2011). Therefore, we define 2000 as our baseline 
measurement for the present analyses, for which the relationship with mortality had not yet been 
analyzed. 
 Ethics  
All participants, in the Zutphen Elderly Study and the Cretan Elderly Study, provided written 
informed consent. The Medical Ethics Committee of the Netherlands Organization for Applied 
Scientific Research (TNO) approved The Zutphen Elderly Study, and a local medical ethics 
committee approved The Cretan Elderly Study. The Institutional Review Board at the University 
of Nevada Las Vegas approved the current study.   
 Measurements  
4.3.3.1 Blood samples 
Non-fasting blood samples were collected from the participants. In Zutphen, the samples were 
collected in the morning, kept in a box with cooling elements, and in the afternoon plasma and 
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serum were obtained. EDTA tubes (Becton Dickinson Vacutainer Systems, Plymouth, UK) were 
used to draw blood and prepare the plasma. In Crete, plasma and serum were obtained after 
allowing the blood samples to stand for two hours at room temperature. Samples were stored at 
−30°C in Zutphen and at −80°C in Crete and usually transported within a few days of collection. 
From both Zutphen and Crete, samples were transported, for analyses, to the National Institute 
for Public Health and Environment (RIVM), Bilthoven, The Netherlands, where they were stored 
at −80 °C until analyses. Samples from Crete were transported to the Netherlands on dry ice by 
plane. 
4.3.3.2 Leukocyte telomere length measurement  
An aliquot of 200 μl of buffy coat was used to extract genomic DNA with the QIAamp DNA 
Mini Kit (Qiagen, Venlo, The Netherlands) according to the manufacturer's protocol. The DNA 
was quantified using a Nanodrop instrument (Isogen Life Science, Belgium). Leukocyte TL was 
determined by quantitative polymerase chain reaction (PCR) as described previously (Cawthon, 
2002; Houben et al., 2009). The PCR was performed using a BioRad MyiQ iCycler Single Color 
real-time PCR detection system using iQ SYBR Green Supermix, containing iTaq Polymerase, 
dNTPs, SYBRGreen I, and buffers (BioRad). Cycle threshold or Ct values from the real-time 
PCR technique were converted into kilobase-pairs by using the standard curve of the reference 
cell line. By adding reference DNA to each PCR reaction, a standard curve was created, and the 
absolute TL of the samples was calculated. 
4.3.3.3 Mortality 
The vital status of the participants was verified approximately every five years during 15 years of 
follow-up until September 1, 2015. No one was lost to follow-up both in Zutphen and on Crete. 
The causes of death were coded by an experienced clinical epidemiologist, according to the 
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World Health Organization’s International Classification of Diseases, Ninth Revision (ICD-9 
codes) (Slee, 1978). The underlying cause of death was classified as a cardiovascular disease 
(CVD) if the primary cause of death was ICD-9 Codes 390–459. The clinical epidemiologist was 
blinded to the outcome of TL measurement.  
4.3.3.4 Life span 
Life span or the age-at-death was calculated as the difference between birth date and death date. 
For the 9 (3.4%) participants [Zutphen: 4 (2.8%) and Crete: 5 (4.1%)] who were still surviving 
until September 1, 2015, we imputed their lifespan. 
4.3.3.5 Other variables 
Protocolized structured questionnaires were used to collect data on sociodemographic and 
lifestyle variables (Buijsse, et al., 2007). Covariates for this study, selected based on the 
literature, were age, marital status, smoking, alcohol consumption, physical activity, body mass 
index (BMI), self-rated health, and prevalent chronic diseases (CVD, diabetes and cancer) at 
baseline. 
Information was collected on age (in years and dichotomised into <85 and ≥85 years), marital 
status (binary, unmarried and married), smoking (binary: never, and former/current), and alcohol 
intake obtained from the cross-check dietary history method (binary, yes/no). Physical activity 
was assessed with a validated questionnaire designed for retired men to calculate the total 
minutes per week spent in different physical activities (i.e., walking, cycling, gardening, odd 
jobs, sports, and hobbies) (Caspersen, Bloemberg, Saris, Merritt, & Kromhout, 1991), which was 
further categorized into two levels as: less than 150 min/week, and 150 min/week and above. 
BMI, the ratio of weight/height2 measured in kg/m2, was dichotomized into less than 25 kg/m2, 
and 25 kg/m2 and above. Participants were asked to report their general health status in terms of 
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a 5-point Likert scale (excellent, very good, good, poor, and bad) which was dichotomized into 
healthy (excellent, very good, good), and unhealthy (poor, and bad).  Prevalence of chronic 
diseases (binary, yes/no) was defined as a diagnosis of one or more of these conditions: CVD 
(i.e., stroke and myocardial infarction), diabetes mellitus, and cancer. The disease status was 
determined by a survey questionnaire and verified with hospital discharge data or by information 
from general practitioners. 
 Statistical analyses 
Descriptive data are present as frequency (percentage), mean (±SD) and (range), as applicable. 
TL was dichotomized as short (defined as TL<5 kbp) and long (defined as TL ≥ 5 kbp), based on 
the average TL in our population. Kaplan–Meier curves were used to present crude all-cause and 
CVD mortality risk with reference to short and long TL. Cox proportional hazards regressions, 
with TL treated as a binary (short vs. long) variable, was used to compute the Hazard Ratios 
(HR) with 95% confidence intervals for all-cause and CVD mortality in crude and adjusted 
models. Two multivariable models were developed: Model 1 adjusted for age, self-rated health, 
prevalence of chronic diseases and Model 2 adjusted for age, marital status, smoking, alcohol 
and BMI. Since TL differs by cell type and measurement methods (Blackburn, 2000), which may 
impair the comparability of findings, we used standardized TL in all linear regressions and Cox 
proportional hazards models (per 1-standard-deviation increment in TL). Sensitivity analyses 
examined the hazards models for the men who were free of CVD, diabetes and cancer at 
baseline. Linear regression was used to evaluate the association between continuous measure of 
TL and life span. A 2-tailed p-value less than 0.05 was considered statistically significant. Data 
analyses were performed in SAS 14.1 (SAS Institute Inc., Cary, NC). 
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 Results 
 Participant’s characteristics  
The general characteristics of the study participants at baseline is provided in Table 4-1. In the 
Zutphen cohort, the mean age of the participants was 84 years (range: 79.5-98.2; SD: 3.6), and 
mean TL was 4.8 kbp. Likewise, in the Cretan cohort, the mean age of the participants was 85 
years (range: 79.2-96.1; SD: 4.2), and mean TL was 5.0 kbp. About 33% of the participants from 
Zutphen and 47% from Crete were 85 years or older. The Cretan cohort was slightly older, had 
longer telomeres, and had a lower prevalence of chronic diseases (Table 4-1). There was no 
statistically significant difference in mean TL (adjusted and unadjusted) for sociodemographic 
factors, lifestyle factors and prevalence of chronic diseases, in both Zutphen and Crete (Table 
4-2).  
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Table 4-1. Baseline sociodemographic, lifestyle factors, and mortality characteristics of 
participants in Zutphen and Crete 
Characteristics Zutphen (N=144) Crete (N=122) 
Age (years):    
Mean ± SD (range) 84.0 ± 3.6 (79.5-98.2) 85.0 ± 4.2 (79.2-96.1) 
<85 years, n (%) 97 (67.4) 65 (53.3) 
≥85 years, n (%) 47 (32.6) 57 (46.7) 
Telomere length (kbp):    
Mean ± SD (range) 4.8 ± 0.4 (3.7-6.1) 5.0 ± 0.5 (3.7-7.1) 
Short telomere (<5 kbp, n (%)) 111 (77.1) 64 (52.5) 
Long telomere (≥ 5 kbp, n (%)) 33 (22.9) 58 (47.5) 
Marital status, n (%):   
Unmarried  56 (38.9) 37 (31.4) 
Married  88 (61.1) 81 (68.6) 
Smoking status, n (%):   
Never  39 (27.1) 37 (30.3) 
Former/current 105 (72.9) 85 (69.7) 
Alcohol intake, n (%):   
Yes 110 (76.4) 65 (55.1) 
No 34 (23.6) 53 (44.9) 
Physical activity, n (%):   
< 150 min/week 62 (43.1) 50 (42.4) 
≥ 150 min/week 82 (56.9) 68 (57.6) 
Body mass index (BMI, kg/m2):   
Mean ± SD 25.8 ± 3.7 24.5 ± 4.1 
≥ 25, n (%) 79 (55.2) 46 (42.2) 
< 25, n (%) 64 (44.8) 63 (57.8) 
Self-rated health, n (%)  
  
Healthy 112 (78.3) 55 (47.0) 
Not healthy 31 (21.7) 62 (53.0) 
Chronic diseases1, n (%):   
Present 70 (48.6) 29 (23.8) 
Absent 74 (51.4) 93 (76.2) 
Cardiovascular disease, n (%):   
Present 41 (28.5) 20 (16.4) 
Absent 103 (71.5) 102 (83.6) 
Diabetes, n (%):   
Present 18 (12.5) 10 (8.2) 
Absent 126 (87.5) 112 (91.8) 
Cancer, n (%):   
Present 29 (20.1) 6 (4.9) 
Absent 115 (79.9) 116 (95.1) 
1: Chronic disease was defined as having prevalent cardiovascular disease (i.e., myocardial infarction, 
stroke, and heart failure), cancer, or diabetes mellitus. 
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Table 4-2. Telomere length according to sociodemographic and lifestyle factors in Zutphen and Crete, at baseline 
Characteristics Zutphen (N=144) Crete (N=122) 
 Mean (SEM) P value *Adjusted 
Mean (SEM) 
P value Mean (SEM) P value *Adjusted 
Mean (SEM) 
P value 
Age (years)         
< 85 4.80 (0.04) 0.25 4.75 (0.05) 0.18 5.06 (0.06) 0.09 5.06 (0.09) 0.09 
≥ 85 4.73 (0.04)  4.66 (0.06)  4.91 (0.06)  4.86 (0.09)  
Marital status           
Unmarried  4.79 (0.05) 0.67 4.72 (0.06) 0.73 5.04 (0.09) 0.43 5.02 (0.10) 0.33 
Married  4.77 (0.04)  4.69 (0.05)  4.95 (0.05)  4.91 (0.07)  
Smoking status         
Never  4.69 (0.06) 0.07 4.64 (0.06) 0.07 5.06 (0.09) 0.29 5.03 (0.10) 0.23 
Former/current 4.81 (0.04)  4.77 (0.05)  4.96 (0.05)  4.89 (0.07)  
Alcohol intake         
Yes 4.80 (0.04) 0.13 4.74 (0.05) 0.37 4.99 (0.05) 0.87 4.98 (0.08) 0.65 
No 4.70 (0.05)  4.67 (0.07)  4.97 (0.07)  4.94 (0.09)  
Physical activity         
< 150 min/week 4.81 (0.05) 0.36 4.77 (0.05) 0.08 4.90 (0.08) 0.14 4.93 (0.10) 0.62 
≥ 150 min/week 4.75 (0.04)  4.64 (0.06)  5.04 (0.05)  4.99 (0.08)  
Body mass index         
≥ 25 kg/m2 4.78 (0.04) 0.91 4.68 (0.06) 0.54 4.93 (0.06) 0.36 4.91 (0.09) 0.29 
< 25 kg/m2 4.77 (0.05)  4.72 (0.05)  5.02 (0.07)  5.02 (0.08)  
Self-rated health          
Healthy 4.79 (0.04) 0.41 4.74 (0.05) 0.35 5.03 (0.06) 0.25 4.97 (0.10) 0.82 
Not healthy 4.73 (0.06)  4.67 (0.07)  4.93 (0.06)  4.95 (0.08)  
Chronic diseases1         
Present 4.74 (0.04) 0.25 4.66 (0.05) 0.16 4.89 (0.07) 0.15 4.91 (0.11) 0.40 
Absent 4.81 (0.04)  4.75 (0.06)  5.02 (0.05)  5.01 (0.07)  
Cardiovascular disease         
Present 4.75 (0.05) 0.55 4.64 (0.07) 0.42 4.94 (0.09) 0.58 4.83 (0.16) 0.80 
Absent 4.79 (0.04)  4.69 (0.07)  5.00 (0.05)  4.86 (0.14)  
Diabetes         
Present 4.75 (0.10) 0.77 4.65 (0.09) 0.70 4.79 (0.12) 0.11 4.75 (0.2) 0.35 
Absent 4.78 (0.03)  4.68 (0.05)  5.01 (0.05)  4.94 (0.12)  
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Cancer         
Present 4.74 (0.06) 0.55 4.64 (0.08) 0.56 4.80 (0.14) 0.23 4.79 (0.22) 0.66 
Absent 4.78 (0.03)  4.69 (0.06)  5.00 (0.05)  4.9 (0.12)  
1: Chronic disease was defined as having prevalent cardiovascular disease (i.e., myocardial infarction, stroke, and heart failure), cancer, or diabetes 
mellitus. 
*Adjusted for age, marital status, smoking, alcohol intake, physical activity, body mass index, self-rated health, chronic diseases. 
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 Telomere length and mortality   
In the 15 years of follow-up, there was a total of 257 deaths (Table 4-3); 140 (97.2%) from the 
Zutphen cohort and 117 (95.9%) from Crete. The mean lifespan of men from Crete (91.3 years) 
was slightly higher than men from Zutphen (89.9 years) but they were not statistically 
significant. Results from the Kaplan-Meier analysis of survival, according to dichotomized TL 
groups, showed statistically non-significant differences in all-cause and CVD mortality (Figure 
4-1) between long and short TL groups in both cohorts. In sub-group analysis by age groups, 
there were no statistically significant differences in all-cause mortality between older adults less 
than 85 years) and those 85 years or older in both cohorts (Appendix M). Again, the results from 
Cox proportional hazards regressions (Table 4-3) suggested that TL, as a standardized 
continuous measure, was not significantly associated with all-cause and CVD mortality in the 
combined cohorts. Findings were similarly non-significant when analyzed separately for the 
Zutphen and Cretan cohort. When analyses were limited to men who were free of prevalence of 
chronic diseases at baseline, the null findings persisted for Zutphen and Crete when analyzed 
separately. For the combined cohorts, in the model adjusted for age, marital status, smoking, 
alcohol and BMI, there were statistically significant difference for CVD mortality, with a lower 
HR of 0.46 (95% confidence interval [CI]: 0.22-0.98; P=0.04) (Appendix N). 
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Table 4-3. Hazard ratios of overall and cardiovascular mortality according to telomere 
length 
 Short TL Long TL P value 
Zutphen:    
 No. of men 111 33  
 Cases of all–cause mortality 109 (77.9%) 31 (22.1%)  
     Crude 1.0 (ref.) 0.83 (0.55 - 1.24) 0.35 
     Model 1 1.0 (ref.) 0.89 (0.59 - 1.34) 0.58 
     Model 2 1.0 (ref.) 0.64 (0.41 - 1.00) 0.05 
 Cases of cardiovascular mortality 38 (79.2%) 10 (20.8%)  
     Crude 1.0 (ref.) 1.09 (0.53 - 2.21) 0.82 
     Model 1 1.0 (ref.) 1.00 (0.46 - 2.18) 0.99 
     Model 2 1.0 (ref.) 0.96 (0.42 - 2.23) 0.93 
Crete:    
 No. of men 64 58  
 Cases of all–cause mortality 61 (52.1%) 56 (47.9%)  
     Crude 1.0 (ref.) 0.96 (0.66 - 1.39) 0.84 
     Model 1 1.0 (ref.) 1.28 (0.87 - 1.89) 0.22 
     Model 2 1.0 (ref.) 0.97 (0.64 - 1.46) 0.88 
 Cases of cardiovascular mortality 27 (49.1%) 28 (50.9%)  
     Crude 1.0 (ref.) 0.90 (0.52 - 1.57) 0.71 
     Model 1 1.0 (ref.) 0.86 (0.46 - 1.58) 0.62 
     Model 2 1.0 (ref.) 0.73 (0.38 - 1.40) 0.34 
All participants combined†:    
 No. of men 175 91  
 Cases of all–cause mortality 170 (66.2%) 87 (33.9%)  
     Crude 1.0 (ref.) 0.90 (0.68 - 1.17) 0.42 
     Model 1 1.0 (ref.) 1.03 (0.79 - 1.35) 0.83 
     Model 2 1.0 (ref.) 0.87 (0.65 - 1.16) 0.34 
 Cases of cardiovascular mortality 65 (63.1%) 38 (36.9%)  
     Crude 1.0 (ref.) 0.96 (0.62 - 1.50) 0.86 
     Model 1 1.0 (ref.) 0.95 (0.60 - 1.51) 0.83 
     Model 2 1.0 (ref.) 0.84 (0.51 - 1.37 0.48 
aModel 1: adjusted for age, self-rated health, prevalence of CVD, diabetes and cancer. 
bModel 2: adjusted for age, marital status, smoking, alcohol and BMI. 
†: additionally adjusted for country. 
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Figure 4-1. Figure 1. Kaplan–Meier survival plot for overall (A, B) and cardiovascular mortality (C, D) according to the 
leukocyte telomere length in elderly men from (A) Zutphen and (B) Crete. 
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Pearson’s correlation coefficient showed a non-significant relationship between TL and age-at- 
death in both the Zutphen (r = -0.11, p =0.17) and Crete cohorts (r = 0.01, p =0.89) (Figure 4-2). 
In the regression analysis, we explored the relationship of TL with risk factors, mortality and 
lifespan, but did not find statistically significant associations in either cohort (Appendix O).  
 
Figure 4-2. Relationship between leukocyte telomere length and age at death in Zutphen 
and Crete, 2000.   
 
 Discussion 
 Our study showed that TL was not related to demographic factors, lifestyle factors and 
prevalence of chronic diseases among elderly men in Zutphen and on Crete. TL was also not 
related to lifespan, all-cause and CVD mortality. The findings may be explained by the survival 
effect, since our participants were long surviving healthy and homogeneous older adults.    
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It is hypothesized that lifestyle and environmental stressors upsurge  oxidative stress that will 
increase the telomere attrition rates, resulting into a shortened TL, which would impair survival 
in the long run (von Zglinicki & Martin-Ruiz, 2005). The alleged associations are quoted 
repeatedly, but strong evidence to support these hypotheses is difficult to find. So far, the 
literature on the relationship between TL and mortality has been inconsistent, possibly related to 
the age at the time of TL assessment. The first published literature on the association between TL 
and mortality, by Cawthon et al. (Cawthon, et al., 2003), reported a significant increased risk of 
overall death (HR: 1.86, 95%CI: 1.22-2.83) associated with short TL among individuals aged 
≥60 years. Since then studies have provided evidence in support (Bakaysa, et al., 2007; Epel, et 
al., 2008; Fitzpatrick, et al., 2007; Kimura, et al., 2008) as well as against this observation 
(Bischoff, et al., 2006; Fitzpatrick, et al., 2007; Harris, et al., 2006; Martin-Ruiz, et al., 2005; 
Njajou, et al., 2009). In the largest study conducted so far, a Danish study with 64,637 
participants and 7,607 deaths during 22 years of follow-up, reported modestly increased hazards 
for all-cause (HR:1.40, 95%CI: 1.25-1.57), CVD (HR:1.36, 95%CI: 1.12-1.66), and cancer 
mortality (HR:1.35, 95%CI: 1.11-1.65) among participants in the shortest TL deciles compared 
to those in the longest deciles (Rode, et al., 2015). Similarly, the most recent meta-analysis, 
using data from two large prospective cohort studies, on 12,199 participants aged 43–75 years 
from Germany and the US, corroborated the previous evidence suggesting that TL predicts all-
cause mortality beyond its association with age (Mons et al., 2017). Another recent prospective 
study, with multiple measure of TL, with 10 years follow-up, found no association between 
change in TL and risk of all-cause mortality, cancer, chronic obstructive lung disease, diabetes 
mellitus, ischemic cerebrovascular disease, or ischemic heart disease (Weischer, Bojesen, & 
Nordestgaard, 2014). Thus, our findings supports some of the previously published reports 
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(Bendix, et al., 2014; Bischoff, et al., 2006; Fitzpatrick, et al., 2007; Harris, et al., 2006; Martin-
Ruiz, et al., 2005; Njajou, et al., 2009; Strandberg, et al., 2011; Zekry, et al., 2012) but does not 
support others (Bakaysa, et al., 2007; Cawthon, et al., 2003; Fitzpatrick, et al., 2007; Kimura, et 
al., 2008; Mons, et al., 2017; Rode, et al., 2015).  
A meta-analysis of previous studies showed that human leucocyte TL predicts mortality, but the 
mortality association diminished with increasing age (Boonekamp, Simons, Hemerik, & 
Verhulst, 2013). Consequently in the studies with elderly participants, TL did not significantly 
predict survival (Bischoff, et al., 2006; Martin-Ruiz, et al., 2005; Strandberg, et al., 2011; Zekry, 
et al., 2012). In a recent, well-powered, population-based prospective study (MrOS-Sweden), 
among 2744 older Swedish men with a mean age of 75.5 years, no significant association 
between TL and all-cause or cause-specific mortality was observed (Svensson et al., 2014). Our 
study, included men from The Netherlands and Greece, had older participants than the Swedish 
study, had almost complete mortality follow-up and found similarly non-significant associations.  
The findings of these epidemiological studies are consistent with the idea that the variability in 
TL in a population decreases with increasing age (Bischoff, et al., 2006; Martin-Ruiz, et al., 
2005; Sanders & Newman, 2013). In a previous study (Ghimire, et al., 2019), heterogeneity in 
decline in TL and absence of a linear pattern in the oldest age category (≥80 years) was noted, 
which partially explains the lack of statistical association between TL and survival, as seen in 
ours and other studies conducted among the elderly. Another possible explanation for our null 
findings could be that long TL and low mortality were both causes of continued participation in 
our study of older men, which may have served as a ‘collider’ (in a graphical model with 
inverted forks). Potential bias from the underrepresentation of men with both short TL and a high 
risk of mortality may have weakened the association between long TL and low mortality (i.e., 
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Berkson's paradox). Factors such as frailty, telomerase insufficiency, and oxidative stress which 
has been implicated in telomere attrition in older people, may explain our non-significant 
findings. Several biomarkers associated with health outcomes and the known predictors of 
mortality no longer demonstrate an association in the older elderly (Ben-Ezra & Shmotkin, 2006; 
Forette, 1999; Nybo et al., 2003).  In a large population-based study of 85 year olds, limited 
evidence was found for the role of immune-senescence in frailty, and no evidence for TL, 
markers of oxidative stress or DNA damage and repair (Collerton et al., 2012). Furthermore, two 
recent studies, a study from California (Lapham et al., 2015), and another from Costa Rica 
(Rehkopf, et al., 2013), provide some evidence of a reversed trend in telomere shortening with 
increasing age among participants with extreme longevity, defined as above 75 years in 
California study and 95 years and above in Costa Rica study. The observed reversed trends in the 
oldest-old suggest selection for survival and the survival bias might explain non-significant 
associations of TL with mortality and lifespan.   
Notably, our participants were males and previous studies suggest a gender difference in survival 
with reference to TL (Epel, et al., 2008). In previous studies, shorter TL and telomere-associated 
single nucleotide polymorphisms were associated with CVD mortality only in women (Burnett-
Hartman et al., 2012; Epel, et al., 2008). In another study, TL declined gradually throughout life 
span only in women, but in men, TL declined marginally only (Bischoff et al., 2005). Although 
the specific reason for gender difference in variability in TL and survival is unknown, sex 
steroids have been shown to affect telomerase activity and estrogen has been indicated to 
increasing telomerase activity (Liu & Li, 2010) whereas androgens may either increase or 
decrease the activity of telomerase (Calado et al., 2009)(Moehren et al., 2008).  
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 Strengths and limitations  
The generalizability of our findings may be limited due to homogeneous participants, i.e., long-
surviving white elderly males. Thus, findings may not be generalized to younger age groups, 
females and different ethnic groups. Our sample size in both cohorts was small. However, the 
study also has strengths, such as high reliability of TL analysis in one laboratory, and a complete 
mortality follow-up. Furthermore, it is one of the few studies assessing the relationship between 
TL and life span at the end of life. Future studies should evaluate whether TL differentiates 
survival among an elderly population, surviving to an advanced age, including women and other 
racial and ethnic groups. 
 Conclusions  
In conclusion, in our population of elderly men from Zutphen and Crete, TL was not related to 
lifespan, all-cause and cardiovascular mortality. 
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Chapter 5. Conclusions 
With an overall aim to study the relationships between TL, a biomarker of aging, with nutrition 
and mortality, this dissertation included three distinct but ancillary studies, following the 
multiple paper dissertation format. The first and second study used data from NHANES (1999-
2002) and the third study used data from the Zutphen and Cretan Elderly Study (2000).  
The first study examined cross-sectional rates of age-related TL change and evaluated variability 
in the rate by gender, chronic stress, and chronic diseases, finding that the population rate of 
decline in TL with age was significantly greater for certain age groups, for males and for those 
with high allostatic load and a history of comorbidities. Analyses by gender was interesting and 
showed a fairly consistent, yet statistically non-significant decline for males; however, a decline 
in the rate was observed for females in the age categories 20-29 years and 50-59 years. Further, 
among women, a significant inverse association was found between TL and parity, menopause, 
and age at menopause. Particularly, the effect modification by gender was useful in elucidating 
the at-risk populations, i.e., females in their twenties and fifties, who could benefit from targeted 
interventions aimed at preserving telomeres.  
The second study comprehensively examined the role of specific nutrients and a HEI in 
attenuating or preserving TL and found that dietary intake of potassium, Vitamin B2 (riboflavin), 
and the overall HEI score were positively associated with TL. Nutrition is an important factor 
contributing to longevity and healthy aging (Bengmark, 2006; Kiefte-de Jong, Mathers, & 
Franco, 2014). Although discovery of the “elixir” for long life is ever elusive, the importance of 
healthy eating for overall health benefits, healthy aging, and preserving telomeres should be 
emphasized, given that optimum nutrition is an easier to achieve and relatively inexpensive 
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public health intervention compared to intensive medical interventions. Further, healthy dietary 
habits are proactive rather than reactive, preventing disease rather than treating it after often 
irreversible damage has been done. Nonetheless, malnutrition is indisputably a prominent 
problem among the geriatric population (Lee & Frongillo, 2001; Pillsbury, et al., 2010).  
The third study assessed the association of TL with survival and lifespan and did not show 
statistically significant differences in all-cause or cardiovascular mortality between long and 
short TL groups. Also, TL was not a significant predictor of age at death for all men combined or 
analyzed separately for the Zutphen and Cretan cohort. The findings are consistent with the 
literature, which posits that among the highly selective sample of long-surviving individuals, TL 
does not determine survival.  
Aging is a relatively new area of research. As the proportion of elderly in the population grows 
globally, the demand for attention for elderly health increases. Current research is focused on 
promoting a healthy aging experience among “baby boomers” and the burgeoning elderly 
populations (World Health Organization, 2011). Therefore, in line with current 
recommendations, the findings in this dissertation align with the health promotion and 
prevention goals of public health. Healthy aging is not just an effect of fate, but the consequence 
of a complex interweaving between environmental and genetic factors (Sharpless & DePinho, 
2007). Findings from these three studies provide a better understanding of the relationship 
between TL and health outcomes, nutrition, and mortality. With TL serving as a potential 
biomarker of aging, understanding telomere dynamics and epidemiology may provide new 
insights to promoting healthy aging.  
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Appendix A.  Comorbid conditions included in Charlson’s 
Comorbidity Index 
SN Condition  Definition of the condition Weight  
1.  Myocardial infarction Participant’s self-report of ever being diagnosed 
with a heart attack or myocardial infarction. 
1 
2.  Congestive heart failure Participant’s self-report of ever being diagnosed 
with congestive heart failure. 
1 
3.  Peripheral vascular disease  Ankle Brachial Blood Pressure Index of <0.90 in 
either leg [1].  
1 
4.  Cerebrovascular disease Participant’s self-report of ever being diagnosed 
with stroke or cerebrovascular disease. 
1 
5.  Dementia Cognitive functioning was assessed by the Wechsler 
Adult Intelligence Scale (WAIS), third edition [2]. 
Dementia was defined as a score of more than 1.5 
SD from mean WAIS or use of dementia medication 
(galantamine, rivastigmine, memantine, donepezil, 
or tacrine) [3]. 
1 
6.  Pulmonary disease Participant’s self-report of ever being diagnosed 
with asthma or chronic bronchitis or wheezing in the 
chest. 
1 
7.  Connective tissue disorder Connective tissue disorder was defined as 
participant’s self-report of ever being diagnosed 
with arthritis, or rheumatoid arthritis or 
osteoporosis; currently taking prescription 
antirheumatic drugs or glucocorticoid medications 
or prednisone or cortisone.  
1 
8.  Liver disease Participant’s self-report of ever being diagnosed 
with a liver condition. 
1 
9.  Diabetes Diabetes was defined as: a previous diagnosis of 
diabetes, or current use of diabetic pills or insulin, or 
a hemoglobin A1c level of 6.5% or greater, or a 
fasting plasma glucose level of ≥126 mg/dL, or 2-
hour plasma glucose level of ≥200 mg/dL [4].   
1 
10.  Diabetes complications Diabetes complications were considered if the 
participant reported retinopathy, unhealed ulcer/sore 
within four weeks, numbness in hands-feet, 
pain/tingling in hands feet and pain in either leg 
while walking due to diabetes. 
2 
11.  Renal disease Renal disease was defined by ever diagnosis of 
weak/failing kidneys or received dialysis in past 12 
months, or a glomerular filtration rate (GFR)< 60 
[5], or presence of microalbuminuria (urine 
albumin-to-creatinine ratio of ≥30 mg/g) [6]. GFR 
was estimated using the equation developed by 
Modification of Diet in Renal Disease Study Group 
[5]. 
2 
12.  Cancer  Participant’s self-report of ever being diagnosed 
with cancer or malignancy of any type. 
2 
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13.  Leukemia  Participant’s self-report of ever being diagnosed 
with leukemia. 
2 
14.  Lymphoma  Participant’s self-report of ever being diagnosed 
with lymphoma. 
2 
15.  Moderate or severe liver disease Participant’s self-report of ever being diagnosed 
with a liver condition. 
3 
16.  HIV Laboratory confirmed cases with HIV antibody. 6 
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Appendix B.  Multivariable regression for factors associated with 
telomere length- NHANES 1999-2002 
  Adjusted Model a 
  β 95%CI p-value 
 Age  -0.0141 -0.0157, -0.0126 <0.001 
Gender (Reference= Male) 
   
 Female 0.0165 -0.0354, 0.0684 0.5204 
Race/Ethnicity (Reference= NH White) 
   
 Hispanic 0.0948 -0.0477, 0.2372 0.184 
 NH Black 0.1948 0.0987, 0.2909 0.0003 
 Other 0.0269 -0.1179, 0.1718 0.7065 
Educational Status (Reference=High School) 
   
 <12th Grade -0.1717 -0.2357, -0.1078 <0.001 
 College Graduate 0.0237 -0.0421, 0.0895 0.4677 
Marital Status (Reference= Married/with Partner)    
    
    
Divorced/Widowed/Separated -0.1283 -0.1895, -0.0672 0.0002 
 Never Married 0.2860 0.2148, 0.3572 <0.001 
Family PIR -0.0224 -0.0495, 0.0047 0.1016 
Smoking (Reference=Smokers) 
   
 Non-smokers 0.0433 -0.016, 0.1026 0.146 
Alcohol use (Reference= Abstainers) 
   
 Moderate drinker -0.0995 -0.1942, -0.0048 0.0401 
 Heavy drinker 0.0385 -0.0819, 0.1589 0.518 
Physical Activity (Reference=Physically active) 
   
 Physically inactive -0.0985 -0.1436, -0.0534 <0.001 
Biomarkers of allostatic load    
Systolic blood pressure -0.0024 -0.0039, -0.0009 0.0027 
Diastolic blood pressure 0.0037 0.0019, 0.0054 0.0002 
Heart rate -0.0004 -0.0024, 0.0016 0.6809 
Total cholesterol -0.0001 -0.0006, 0.0005 0.8304 
High-density lipoprotein cholesterol 0.0013 -0.0008, 0.0034 0.2252 
BMI (kg/m2) -0.0100 -0.0138, -0.0062 <0.001 
Glycosylated hemoglobin -0.0237 -0.0443, -0.0032 0.0253 
C-reactive protein -0.0412 -0.0864, 0.004 0.0726 
Albumin  0.2563 -0.4608, 0.9735 0.4706 
Allostatic load (Reference=Low)    
High -0.1487 -0.2053, -0.0921 <0.001 
Charleston Comorbidity Index -0.0649 -0.0744, -0.0555 <0.001 
DV: Telomere length in kbp; a Adjusted for gender, race/ethnicity, education, PIR, and BMI. Abbreviations: BMI: body mass index, CI: 
confidence interval, NH: Non-Hispanic, PIR: poverty income ratio. p-value less than 0.05 are bold. 
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Appendix C. Association between telomere length and parity in 
NHANES 1999-2002 
 
Appendix C footnote: Y-axis represents the slope of change in telomere length with the 
number of live births. Regression coefficients adjusted for ethnicity, education, poverty 
income ratio, and body mass index. 
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Appendix D. Association between telomere length and years passed 
since menopause, by BMI status of women in NHANES 1999-2002 
 
Appendix D footnote: The slope for each weight category is: Normal weight (β= -0.0101; 
p =0.001), Overweight (β= -0.0111; p =0.005) and Obese (β= -0.0076; p= 0.007). 
Estimates adjusted for ethnicity, education, poverty income ratio, and body mass index. 
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Appendix E. The nutrients assessed in manuscript 2 and their age 
and sex specific recommended daily intake 
Nutrients (Unit) Recommended daily intake (Unit/day) 
Males Females 
19–
30 y 
31–
50 y 
51–
70 y 
> 70 y 19–
30 y 
31–
50 y 
51–
70 y 
> 70 y 
Macronutrients         
Carbohydrate (gm) 130 130 130 130 130 130 130 130 
Protein (gm) 56 56 56 56 46 46 46 46 
Dietary fiber (gm) 38 38 30 30 25 25 21 21 
Total fat (gm)  Not determined 
Total saturated fatty acids 
(gm) 
Not determined 
Total monounsaturated 
fatty acids (gm) 
Not determined 
Total polyunsaturated 
fatty acids (gm) 
Not determined 
Cholesterol (mg) Not determined 
Elements                 
Calcium (mg) 1,000 1,000 1,000 1,200 1,000 1,000 1,200 1,200 
Copper (μg) 900 900 900 900 900 900 900 900 
Iron (mg) 8 8 8 8 18 18 8 8 
Magnesium (mg) 400 420 420 420 310 320 320 320 
Phosphorus (mg) 700 700 700 700 700 700 700 700 
Selenium (μg) 55 55 55 55 55 55 55 55 
Zinc (mg) 11 11 11 11 8 8 8 8 
Potassium (g) 4700 4.7 4.7 4.7 4.7 4.7 4.7 4.7 
Sodium (g) 1.5 1.5 1.3 1.2 1.5 1.5 1.3 1.2 
Vitamins                  
Vitamin A (μg) 900 900 900 900 700 700 700 700 
Thiamin (Vitamin B1) 
(mg) 
1.2 1.2 1.2 1.2 1.1 1.1 1.1 1.1 
Riboflavin (Vitamin B2) 
(mg) 
1.3 1.3 1.3 1.3 1.1 1.1 1.1 1.1 
Niacin (Vitamin B3) (mg) 16 16 16 16 14 14 14 14 
Vitamin B6 (mg) 1.3 1.3 1.7 1.7 1.3 1.3 1.5 1.5 
Vitamin B12 (μg) 2.4 2.4 2.4h 2.4h 2.4 2.4 2.4h 2.4h 
Folate (μg) 400 400 400 400 400 400 400 400 
Vitamin C (mg) 90 90 90 90 75 75 75 75 
Vitamin E (mg) 15 15 15 15 15 15 15 15 
Vitamin K (μg) 120 120 120 120 90 90 90 90 
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Appendix F. Healthy Eating Index: components and standards for 
scoring 
  
SN Component Score 
ranges 
Criteria for minimum score 
of 0 
Criteria for maximum score 
of 10 
1.  Grain consumption 0 to 10 0 servings 6 - 11 servings 
2.  Vegetable 
consumption 
0 to 10 0 servings 3 - 5 servings 
3.  Fruit consumption 0 to 10 0 servings 2 - 4 servings 
4.  Milk consumption 0 to 10 0 servings 2 - 3 servings 
5.  Meat consumption 0 to 10 0 servings 2 - 3 servings 
6.  Total fat intake 0 to 10 45% or more energy from fat 30% or less energy from fat 
7.  Saturated fat intake 0 to 10 15% or more energy from 
saturated fat 
Less than 10% energy from 
saturated fat 
8.  Cholesterol intake 0 to 10 450 mg or more 300 mg or less 
9.  Sodium intake 0 to 10 4800 mg or more 2400 mg or less 
10.  Variety 0 to 10 3 or fewer different items 
in a day 
8 or more different items 
in a day 
 Total HEI score 0-100   
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Appendix G. Definition of chronic conditions  
 
SN Condition  Definition of the condition 
1.  Diabetes Diabetes was defined as: a previous diagnosis of diabetes, or current use of 
diabetic pills or insulin, or a hemoglobin A1c level of 6.5% or greater, or a 
fasting plasma glucose level of ≥126 mg/dL, or 2-hour plasma glucose level of 
≥200 mg/dL [1].   
2.  Cardioascular 
disease 
Participant’s self-report of ever being diagnosed with congestive heart failure, 
coronary heart disease, angina pectoris, heart attack, and stroke. 
3.  Cancer  Participant’s self-report of ever being diagnosed with cancer or malignancy of 
any type. 
4.  Kidney 
disease 
Renal disease was defined by ever diagnosis of weak/failing kidneys or received 
dialysis in past 12 months, or a glomerular filtration rate (GFR)< 60 [2], or 
presence of microalbuminuria (urine albumin-to-creatinine ratio of ≥30 mg/g) 
[3]. GFR was estimated using the equation developed by Modification of Diet in 
Renal Disease Study Group [2]. 
5.  Liver disease Participant’s self-report of ever being diagnosed with a liver condition. 
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Appendix H. Nutrients intake of the study participants by quartiles of leukocyte telomere 
length- NHANES 1999-2002 
 Overall (N= 6645) Quartiles, Mean ± SEM 
Total nutrients intake N Mean ± SEM One 
(N=1917) 
Two 
(N=1703) 
Three 
(N=1625) 
Four 
(N=1400) 
p-value 
Energy (kcal) 6645 2172.2 ±18.2 2038.6 ±29.0 2155.6 ±32.3 2208.0 ±33.7 2288.2 ±33.7 <0.001 
Macronutrients        
Carbohydrate (gm) 6645 271.1 ± 3.0 253.1 ± 3.4 267.7 ± 4.8 274.3 ± 4.8 289.6 ± 4.3 <0.001 
Protein (gm) 6645 81.3 ± 0.8 76.4 ± 1.3 80.6 ± 1.4 84.1 ± 1.6 84.2 ± 1.5 <0.001 
Dietary fiber (gm) 6645 15.9 ± 0.3 16.0 ± 0.5 15.7 ± 0.4 15.6 ± 0.4 16.4 ± 0.5 0.0003 
Total fat (gm) 6645 81.2 ± 0.8 78.2 ± 1.6 81.9 ± 1.4 81.5 ± 1.7 83.2 ± 2.0 <0.001 
Total saturated fatty acids (gm) 6645 26.5 ± 0.3 25.1 ± 0.5 26.6 ± 0.5 26.9 ± 0.7 27.5 ± 0.7 <0.001 
Total monounsaturated fatty acids (gm) 6645 30.3 ± 0.3 29.1 ± 0.7 30.5 ± 0.6 30.2 ± 0.6 31.2 ± 0.8 <0.001 
Total polyunsaturated fatty acids (gm) 6645 16.8 ± 0.2 16.4 ± 0.4 17.0 ± 0.4 16.7 ± 0.4 16.9 ± 0.5 0.0193 
Elements        
Calcium (mg) 6645 852.8 ± 13.0 797.4 ± 20.4 846.2 ± 18.8 878.3 ± 27.6 889.8 ± 21.2 <0.001 
Copper (μg) 6645 1329.4 ± 29.1 1274.8 ± 29.0 1341.5 ± 69.5 1321.8 ± 32.1 1380.0 ± 42.4 0.0001 
Iron (mg) 6645 15.5 ± 0.3 15.2 ± 0.4 15.2 ± 0.4 15.4 ± 0.4 16.2 ± 0.4 <0.001 
Magnesium (mg) 6645 284.4 ± 4.3 276.1 ± 6.1 281.1 ± 5.1 285.6 ± 5.8 295.1 ± 7.3 <0.001 
Phosphorus (mg) 6645 1322.1 ± 13.6 1250.2 ± 22.2 1308.2 ± 20.2 1360.3 ± 28.7 1370.3 ± 26.2 <0.001 
Selenium (μg) 6645 108.2 ± 1.3 103.1 ± 1.9 108.0 ± 1.9 111.1 ± 2.4 110.7 ± 2.3 <0.001 
Zinc (mg) 6645 11.9 ± 0.2 11.4 ± 0.3 11.9 ± 0.3 12.1 ± 0.3 12.2 ± 0.3 <0.001 
Potassium (g) 6645 2.8 ± 0.0 2.7 ± 0.1 2.8 ± 0.1 2.8 ± 0.0 2.8 ± 0.1 0.0029 
Sodium (g) 6645 3.4 ± 0.0 3.3 ± 0.1 3.4 ± 0.1 3.5 ± 0.1 3.6 ± 0.1 <0.001 
Vitamins         
Vitamin A (μg) 6645 787.2 ±24.9 791.0 ±31.6 793.5 ±54.9 793.4 ±39.0 770.8 ±47.2 0.7225 
Thiamin (Vitamin B1) (mg) 6645 1.6 ± 0.0 1.6 ± 0.0 1.6 ± 0.0 1.7 ± 0.1 1.7 ± 0.1 <0.001 
Riboflavin (Vitamin B2) (mg) 6645 2.1 ± 0.0 2.0 ± 0.0 2.1 ± 0.0 2.1 ± 0.1 2.1 ± 0.1 <0.001 
Niacin (Vitamin B3) (mg) 6645 23.0 ± 0.3 22.0 ± 0.4 22.8 ± 0.5 23.3 ± 0.5 23.9 ± 0.6 <0.001 
Vitamin B6 (mg) 6645 1.9 ± 0.0 1.8 ± 0.0 1.9 ± 0.1 1.9 ± 0.0 1.9 ± 0.1 <0.001 
Vitamin B12 (μg) 6645 5.2 ± 0.2 5.0 ± 0.2 5.2 ± 0.4 5.6 ± 0.4 5.0 ± 0.2 0.0045 
Folate (μg) 6645 398.6 ± 8.3 383.3 ±10.5 394.0 ± 9.6 396.0 ±10.7 421.3 ±13.4 <0.001 
Vitamin C (mg) 6645 95.7 ± 3.4 92.0 ± 3.5 91.7 ± 3.5 96.6 ± 5.1 102.6 ± 6.5 <0.001 
Vitamin E (mg) 6645 8.1 ± 0.1 8.3 ± 0.3 8.1 ± 0.3 8.0 ± 0.2 8.2 ± 0.3 0.1326 
Vitamin K (μg) 3594 91.6 ± 4.7 91.4 ± 6.9 88.8 ± 6.7 91.9 ± 3.8 94.3 ±10.5 0.3071 
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Appendix I. Subgroup analyses: regression of telomere length (base pairs) on different 
nutrients by age and gender- NHANES 1999-2002 
Adjusted models1 
Nutrients 20-44 45-64 65-85 Male Female 
ß 95% CI ß 95% CI ß 95% CI ß 95% CI ß 95% CI 
Macronutrients   
         
Carbohydrate (gm) 74.71 -80.71, 230.13 136.93 -70.24, 344.10 114.03 -62.61, 290.66 67.24 -71.39, 205.87 172.19 19.83, 324.55 
Protein (gm) 20.43 -113.56, 
154.42 
20.54 -126.68, 167.77 46.93 -157.74, 251.59 -25.58 -184.29, 133.13 76.89 -78.50, 232.29 
Dietary fiber (gm) -12.54 -110.04, 84.97 -1.99 -97.58, 93.60 22.67 -97.88, 143.23 11.86 -36.93, 60.65 -18.93 -126.22, 88.35 
Total fat (gm) -48.79 -158.58, 61.00 -165.94 -339.20, 7.32 -85.41 -313.56, 142.75 -72.32 -168.85, 24.22 -98.5 -192.03, -4.97 
Total saturated fatty 
acids (gm) 
-18.17 -103.32, 66.98 -95.85 -287.49, 95.79 -79.01 -249.68, 91.67 -22.84 -121.30, 75.62 -84.01 -162.90, -5.11 
Total monounsaturated 
fatty acids (gm) 
-63.16 -166.08, 39.75 -193.3 -335.79, -50.80 -150.62 -346.95, 45.71 -100.44 -198.23, -2.64 -111.5 -218.69, -4.31 
Total polyunsaturated 
fatty acids (gm) 
-56.36 -133.75, 21.03 -67.14 -182.27, 47.99 -17.37 -135.55, 100.80 -74.67 -140.68, -8.65 -41.8 -106.86, 23.26 
Elements   
         
Calcium (mg) 29.76 -54.84, 114.37 47.34 -82.93, 177.60 -71.68 -171.18, 27.82 12.47 -58.96, 83.90 20.84 -102.03, 143.71 
Copper (µg) 69.84 -56.91, 196.60 12.74 -103.94, 129.41 117.59 -28.14, 263.32 100.75 -25.33, 226.83 -3.43 -134.81, 127.95 
Iron (mg) 43.63 -53.87, 141.13 28.11 -102.13, 158.35 -31.06 -169.68, 107.56 9.57 -86.52, 105.66 52.94 -54.29, 160.16 
Magnesium (mg) 54.55 -93.94, 203.05 92.82 -82.17, 267.80 70.4 -101.36, 242.15 90.86 -35.06, 216.78 22.66 -139.20, 184.53 
Phosphorus (mg) -26.93 -212.21, 
158.35 
123.79 -98.85, 346.42 17.12 -160.53, 194.77 -20.43 -183.07, 142.21 57.73 -100.75, 216.21 
Selenium (µg) -34.99 -138.40, 68.43 -52.73 -186.30, 80.84 124.35 -26.02, 274.72 -36.57 -135.84, 62.70 8.87 -123.07, 140.81 
Zinc (mg) 50.53 -53.45, 154.50 65.98 -87.96, 219.92 0.36 -95.55, 96.28 47.45 -35.86, 130.75 55.09 -34.65, 144.83 
Potassium (g) 80.09 -42.52, 202.71 99.77 -37.86, 237.40 94.76 -89.64, 279.16 117.71 -5.42, 240.85 50.84 -132.13, 233.81 
Sodium (g) 52.86 -108.20, 
213.92 
-70.28 -186.76, 46.19 -158.32 -374.69, 58.06 28.85 -112.93, 170.63 -92.41 -203.45, 18.62 
Vitamins   
         
Vitamin A (µg) -29.51 -106.91, 47.88 21.2 -38.96, 81.37 -18.96 -95.38, 57.46 1.7 -49.11, 52.51 -20.01 -96.40, 56.39 
Thiamin (Vitamin B1) 
(mg) 
49.27 -53.78, 152.33 101.48 -37.28, 240.24 -32.11 -151.81, 87.58 75.03 -14.16, 164.22 34.55 -69.27, 138.36 
Riboflavin (Vitamin 
B2) (mg) 
91.98 -6.95, 190.92 84.29 -69.00, 237.57 34.91 -105.02, 174.84 119.24 19.58, 218.90 54.77 -49.35, 158.89 
Niacin (Vitamin B3) 
(mg) 
4.55 -97.00, 106.10 -54.35 -212.50, 103.81 -63.06 -206.47, 80.35 -98.79 -250.76, 53.19 59.83 -47.09, 166.75 
Vitamin B6 (mg) 14.98 -84.58, 114.55 161.87 58.39, 265.35 -23.71 -134.42, 87.01 3.18 -92.96, 99.32 106.84 -12.75, 226.42 
Vitamin B12 (µg) 11.7 -58.79, 82.19 33.71 -52.21, 119.63 -19.49 -65.19, 26.22 13.54 -41.94, 69.02 18.14 -41.58, 77.87 
Folate (µg) 31.44 -66.30, 129.19 75.49 -59.30, 210.28 -42.51 -167.92, 82.90 47.65 -59.41, 154.70 25.81 -92.70, 144.32 
Vitamin C (mg) 13.11 -41.65, 67.88 30.48 -2.71, 63.68 -14.67 -60.87, 31.53 23.78 -7.81, 55.38 10.53 -52.85, 73.91 
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Vitamin E (mg) -55.68 -138.60, 27.24 -48.97 -153.24, 55.29 21.05 -90.33, 132.42 -43.5 -119.79, 32.80 -54.37 -123.09, 14.35 
Vitamin K (µg) 17.74 -58.37, 93.85 11.63 -59.11, 82.37 -1.89 -98.96, 95.18 45.7 -18.88, 110.28 -7.74 -77.08, 61.60 
1Adjusted for energy, age, age-squared, sex, race/ethnicity, marital status, education, socio-economic status, BMI, smoking, alcohol use, and physical activity. 
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Appendix J. Sensitivity analyses: regression of telomere length (base pairs) on different 
nutrients among dietary supplement non-users, and participants without chronic diseases, 
NHANES 1999-2002   
Nutrients Healthy participants Participants without dietary supplement use 
ß1 95% CI ß1 95% CI 
Macronutrients         
Carbohydrate (gm) 63.92 -74.13, 201.97 146.21 40.64, 251.78 
Protein (gm) 11.02 -108.17, 130.20 49.71 -42.45, 141.88 
Dietary fiber (gm) -29.29 -109.26, 50.69 19.97 -45.34, 85.27 
Total fat (gm) -69.05 -152.55, 14.45 -49.09 -181.46, 83.29 
Total saturated fatty acids (gm) -28.37 -114.58, 57.85 -16.01 -132.52, 100.50 
Total monounsaturated fatty acids (gm) -104.62 -184.44, -24.80 -81.05 -178.97, 16.86 
Total polyunsaturated fatty acids (gm) -55.01 -117.19, 7.18 -65.23 -154.63, 24.16 
Elements         
Calcium (mg) 6.91 -64.20, 78.02 37.5 -43.34, 118.33 
Copper (µg) 44.45 -51.27, 140.16 57.14 -72.41, 186.70 
Iron (mg) 23.6 -89.39, 136.59 66.31 -49.17, 181.80 
Magnesium (mg) 65.72 -46.91, 178.36 49.81 -90.25, 189.87 
Phosphorus (mg) -13.93 -125.13, 97.26 -3.65 -141.91, 134.60 
Selenium (µg) -70.86 -196.98, 55.26 12.68 -99.92, 125.28 
Zinc (mg) 84.8 -8.43, 178.03 61.39 -27.85, 150.63 
Potassium (g) 93.04 -0.92, 187.00 153.16 54.61, 251.71 
Sodium (g) -43.48 -162.57, 75.62 76.27 -74.96, 227.51 
Vitamins         
Vitamin A (µg) -1.35 -68.31, 65.61 -0.18 -65.97, 65.60 
Thiamin (Vitamin B1) (mg) 33.76 -69.03, 136.54 104.06 -10.24, 218.36 
Riboflavin (Vitamin B2) (mg) 71.69 -23.71, 167.08 117.55 27.12, 207.98 
Niacin (Vitamin B3) (mg) -18.87 -123.58, 85.84 0.03 -114.82, 114.88 
Vitamin B6 (mg) 77.93 -8.01, 163.86 54.55 -33.12, 142.23 
Vitamin B12 (µg) 33.89 -20.58, 88.36 21.65 -28.40, 71.70 
Folate (µg) 20.3 -81.51, 122.11 19.92 -75.87, 115.72 
Vitamin C (mg) 14.17 -27.47, 55.80 27.12 -17.88, 72.12 
Vitamin E (mg) -62.54 -120.21, -4.87 -21.31 -117.42, 74.80 
Vitamin K (µg) 29.37 -25.70, 84.43 55.04 -17.71, 127.79 
1Adjusted for energy, age, age-squared, sex, race/ethnicity, marital status, education, socio-economic status, BMI, smoking, alcohol use, and physical activity.
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Appendix K. Multivariable regression of telomere length (base 
pairs) on different components of Healthy Eating Index- NHANES 
1999-2002 
Healthy Eating Index components 
Model 1– energy adjusted 
1Model 2– energy + 
demographic + health-related 
behaviors adjusted 
β 95% CI p-value β 95% CI 
p-
value 
Grain intake score -2.50 -11.03, 6.03 0.553 -3.67 -15.35, 8.02 0.526 
Vegetable intake score 0.18 -5.86, 6.22 0.952 3.04 -5.02, 11.10 0.447 
Fruit intake score -2.93 -11.57, 5.71 0.494 13.56 4.11, 23.01 0.007 
Dairy intake score 4.33 -2.44, 11.11 0.201 2.04 -7.29, 11.38 0.658 
Meat/meat alternatives intake score 2.99 -3.66, 9.63 0.365 -1.71 -9.02, 5.59 0.635 
Total fat intake score 10.18 3.18, 17.17 0.006 8.33 -2.50, 19.15 0.127 
Saturated fat intake score 4.19 -0.99, 9.37 0.109 6.47 -3.99, 16.93 0.216 
Cholesterol intake score -2.37 -8.01, 3.26 0.396 -0.22 -10.15, 9.72 0.965 
Sodium intake score -7.35 -14.34, -0.35 0.040 0.05 -9.03, 9.13 0.991 
Variety score 3.15 -7.53, 13.83 0.551 10.63 -1.55, 22.81 0.085 
1Adjusted for energy, age, age-squared, sex, race/ethnicity, marital status, education, socio-economic status, BMI, 
smoking, alcohol use, and physical activity. 
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Appendix L. Literature review on nutrition and telomere length 
Nutrient Epidemiological evidence Possible biological mechanism 
Folate Plasma folate concentration above the 
median was positively associated with 
telomere length but plasma folate 
concentration below the median was 
inversely associated with telomere 
length (Paul et al., 2009). 
Methylene-tetrahydrofolate (THF) is used for the 
synthesis of the pyrimidine thymidylate and of purines, 
thus providing precursors for DNA synthesis. Thus, 
folate plays an important role in maintenance of DNA 
integrity and DNA methylation, both of which influence 
telomere length (Paul, et al., 2009). 
Vitamin 
B12 
No association between telomere length 
and vitamin B12, intake and plasma 
concentration, (Paul, et al., 2009; Xu, et 
al., 2009) but women who use vitamin 
B12 supplements have longer telomeres 
than nonusers (Xu, et al., 2009). 
Vitamin B12 plays a role in generation of methyl groups 
for methylation reactions (Paul, 2011). Additionally, the 
strong antioxidant and anti- inflammatory properties of 
Vitamin B12 may help in preservation of telomeres 
(Paul, 2011). 
Vitamin A Telomere length is positively 
associated with dietary intake of 
vitamin A and β-carotene in women 
who do not take multivitamins (Xu, et 
al., 2009). 
Vitamin A plays an important role in immune 
response (Mora, Iwata, & von Andrian, 2008)). 
Deficiency of vitamin A predisposes individuals to 
infections (Aukrust et al., 2000) that can lead to 
telomere attrition. 
Vitamin D A positive association between 
serum concentration of vitamin D and 
telomere length in women (Richards et 
al., 2007). 
The biologically active form of vitamin D, 1α,25 
dihydroxyvitamin D3, possesses immunosuppressive 
properties (Mora, et al., 2008) and is inversely related to 
the inflammatory marker CRP (Oelzner et al., 1998). In 
addition, vitamin D also reduces the expression of 
inflammation mediators interleukin-2 (Lemire et al., 
1985) and interferon gamma (Reichel, Koeffler, Tobler, 
& Norman, 1987). These anti-inflammatory 
and antiproliferative properties of vitamins D limit 
the turnover of cells, thus potentially reducing their 
telomere length attrition. 
Vitamins C 
and E 
Intake of vitamin C and E is positively 
associated with longer telomeres in a 
dose-dependent manner in women (Xu, 
et al., 2009). 
Antioxidant properties of vitamin C and E are widely 
known (Honarbakhsh & Schachter, 2009). They limit 
shortening of telomere length by preventing oxidative 
damage to telomeric DNA (Furumoto, Inoue, Nagao, 
Hiyama, & Miwa, 1998). 
Iron Use of iron supplements is associated 
with shorter telomeres (Aviv, 2009; Xu, 
et al., 2009). But iron intake from diet 
or multivitamins (low dose of iron than 
iron supplements) is not negatively 
associated with telomere length (Xu, et 
al., 2009). 
The shorter telomeres observed in iron supplement users 
could be due the free radical generating capacity of iron 
and resultant oxidative stress which is one of the factors 
that result in telomere attrition (Aviv, 2009). 
Magnesium Dietary magnesium intake is positively 
related to telomere length in women 
(Xu, et al., 2009). 
Magnesium is required for catalytic activity of enzymes 
involved in DNA replication, DNA repair and RNA 
synthesis (Hartwig, 2001). In addition to its potential 
role in DNA integrity and repair, magnesium may also 
affect telomere length by oxidative stress and 
inflammation (Martin et al., 2008). 
 84 
 
Zinc  DNA polymerases, RNA polymerases and reverse 
transcriptases are Zinc-dependent enzymes in the cell 
(Poiesz, Seal, & Loeb, 1974; Terhune & Sandstead, 
1972). Thus, Zince deficiency cause DNA damage 
(Song et al., 2009). In addition, zinc deficiency may also 
affect telomere length through increased oxidative stress 
and susceptibility to infection (Paul, 2011). 
Omega-3 
fatty acids 
Plasma concentration of omega-3 fatty 
acids is positively associated with 
reduced attrition of telomere length 
(Farzaneh-Far, Lin, Epel, Harris, et al., 
2010). 
The anti-inflammatory and antioxidant properties of 
omega-3 fatty acids decrease the cell turnover and 
oxidative DNA damage and thus may reduce telomere 
shortening (Ferrucci et al., 2006). 
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Appendix M. Kaplan–Meier survival plot for overall mortality 
according to the leukocyte telomere length in elderly men 
 
Appendix M footnote: Age group < 85 years from (A) Zutphen and (B) Crete and aged ≥85 from 
(C) Zutphen and (D) Crete. 
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Appendix N. Hazard ratios of overall and cardiovascular mortality 
according to telomere length for men who were free of 
cardiovascular disease, diabetes and cancer 
 Short TL Long TL P value 
Zutphen:    
Cases of all–cause mortality    
     Crude 1.0 (ref.) 0.75 (0.42 - 1.34) 0.33 
     Model 1 1.0 (ref.) 0.84 (0.47 - 1.52) 0.57 
     Model 2 1.0 (ref.) 0.62 (0.32 - 1.19) 0.15 
 Cases of cardiovascular mortality    
     Crude 1.0 (ref.) 0.75 (0.22 - 2.62) 0.65 
     Model 1 1.0 (ref.) 1.14 (0.29 - 4.45) 0.85 
     Model 2 1.0 (ref.) 0.23 (0.03 - 1.78) 0.16 
Crete:    
 Cases of all–cause mortality    
     Crude 1.0 (ref.) 1.00 (0.65 - 1.53) 0.99 
     Model 1 1.0 (ref.) 1.23 (0.79 - 1.91) 0.36 
     Model 2 1.0 (ref.) 0.93 (0.57 - 1.52) 0.77 
 Cases of cardiovascular mortality    
     Crude 1.0 (ref.) 0.81 (0.41 - 1.60) 0.54 
     Model 1 1.0 (ref.) 0.69 (0.32 - 1.48) 0.34 
     Model 2 1.0 (ref.) 0.46 (0.18 - 1.13) 0.09 
All participants combined†:    
 Cases of all–cause mortality    
     Crude 1.0 (ref.) 0.90 (0.64 - 1.27) 0.56 
     Model 1 1.0 (ref.) 1.07 (0.76 - 1.51) 0.70 
     Model 2 1.0 (ref.) 0.89 (0.62 - 1.29) 0.55 
 Cases of cardiovascular mortality    
     Crude 1.0 (ref.) 0.79 (0.44 - 1.44) 0.45 
     Model 1 1.0 (ref.) 0.81 (0.42 - 1.54) 0.52 
     Model 2 1.0 (ref.) 0.46 (0.22 - 0.98) 0.04 
 
Model 1: adjusted for age, self-rated health, prevalence of CVD, diabetes and cancer. 
Model 2: adjusted for age, marital status, smoking, alcohol and BMI. 
†: additionally adjusted for country. 
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Appendix O. Associations between leukocyte telomere length at 
baseline and age at death in Zutphen and Crete 
  β (95% CI) P-value 
Zutphen:   
     Crude -0.11 (-3.33, 0.60) 0.17 
     Model 1 -0.03 (-2.18, 1.36) 0.65 
     Model 2 0.04 (-1.27, 2.22) 0.59 
Crete:   
     Crude 0.01 (-1.63, 1.88) 0.89 
     Model 1 0.04 (-1.09, 1.88) 0.60 
     Model 2 0.07 (-0.94, 2.16) 0.44 
Data are standardized beta-coefficients (β, with the 95% confidence interval [CI]). 
Model 1: adjusted for age, self-rated health, prevalence of CVD, diabetes and cancer. 
Model 2: adjusted for age, marital status, smoking, alcohol and BMI. 
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1. Ghimire S, Sy FS, Rodriguez R. Association between Telomere Length, 31 Nutrients and 
a Healthy Eating Index in the National Health and Nutrition Examination Survey 
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2018. 
2. Cheong P, Coughenour C, Shegog M, Ghimire S, Sagadraca L, Sy FS. An Evaluation of 
Food Insecurity and Its Correlates in a Filipino American Population Sample Residing in 
Clark County, Nevada. American Public Health Association Conference, San Diego, CA, 
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3. Ghimire S, Sy FS, Rodriguez R. Association between Telomere Length, 31 Nutrients and 
a Healthy Eating Index in the National Health and Nutrition Examination Survey 
(NHANES), 1999-2002. American Public Health Association Conference, San Diego, 
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U.S. adults?: National Health and Nutrition Examination Survey (NHANES) 2011-2014. 
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5. Cheong P, Ghimire S, Sagadraca L, Sy FS. An Assessment of Filipino American Health 
in the Greater Las Vegas Area: A Pilot Study. American Public Health Association 
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6. Ghimire S, Shrestha N, Callahan KE. Factors Associated with Health-Related Quality of 
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7. Ghimire S, Baral BK, Callahan KE. Nutritional Assessment of Older Adults in Nepal. 
18th Annual Graduate & Professional Student Research Forum, University of Nevada Las 
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8. Ghimire S, Maheshwari S, Callahan KE, Wu Q. The Risk of Incident Asthma among 
Overweight and Obese Children: A Meta-Analysis of Prospective Studies. Nevada 
Institute of Personalized Medicine, 2016 Retreat. Las Vegas, NV. February 12, 2016. 
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Stromal Cell Therapy for Ischemic Stroke: A Meta-Analysis of Randomized Control 
Animal Trials. Nevada Institute of Personalized Medicine, 2016 Retreat. Las Vegas, NV. 
February 12, 2016. 
10. Palisoc B, Ghimire S, Wu Q. Depression Onset as an Adverse Event of Tetrabenazine on 
Individuals with Huntington’s Disease: Preliminary Results of Systematic Review and 
Meta-Analysis. Nevada Institute of Personalized Medicine, 2016 Retreat. Las Vegas, NV. 
February 12, 2016. 
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1. Research Evaluator: UNLV Office of Undergraduate Research /CSUN Undergrad 
Research Conference, University of Nevada Las Vegas. April 27, 2018.  
2. Presenter: SPSS Fundamentals Workshop. Graduate College and the Graduate & 
Professional Student Association (GPSA), University of Nevada Las Vegas. March 4, 
2016. 
3. Presenter: Operational Research and Report Writing. National Health 
Training Center Teku, Kathmandu. July 8, 2015. 
4. Workshop Leader: Research Proposal Development - Training Workshop. Purbanchal 
University College of Medical and Allied Sciences (PUCMAS), Morang Nepal. June 17-
19, 2015. 
5. Presenter: Data Entry by using Epidata - Training Workshop. AHEAD-Nepal, 
Kathmandu. November 2, 2014. 
6. Workshop Leader: Literature Review, Citation and Referencing by Using EndNote -
Training Workshop. AHEAD-Nepal, Kathmandu. November 5, 2014. 
7. Workshop Leader: Data Management and Analysis by using SPSS - Training Workshop. 
AHEAD-Nepal, Kathmandu. November 8-10, 2014. 
Trainings and Workshops Attended 
1. UNLV Graduate College Communication Certification Program, August 2018-May 2019 
(ongoing). 
2. UNLV Graduate College Research Certification Program, August 2018-May 2019 
(ongoing). 
3. Grad Rebel Writing Boot Camp, August 13-17, 2018, UNLV Graduate College. 
4. Three-day workshop on Meta-Analysis by Dr. Michael Borenstein, April 18-20, 2016 
New York. 
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5. Collaborative Institutional Training Initiative (CITI) Training, Biomedical Responsible 
Conduct of Research, Expires: August 2020. 
6. Research Ethics organized by The Global Health Network, June 2015; Certificate Number 
59144. 
7. Training Workshop on “Data Management and Analysis”, organized by the National 
Health Research Council (NHRC), 08 - 13 March 2015, Kathmandu, Nepal. 
8. National workshop on “Neglected Tropical Disease (NTDs) in Nepal: Identifying the 
Gaps and Mapping the Way Forward”, organized by the National Health Research 
Council (NHRC) and World Health Organization, Country office Nepal, 26-27 March 
2015; Kathmandu, Nepal. 
9. Advanced course “Ethics of Public Health and Biomedicine in a Nutshell" (3 higher 
education credits), Sahlgrenska Academy, University of Gothenburg, Sweden, April 8-12, 
2013; Kathmandu, Nepal. 
Service 
Professional Service as Journal Peer Reviewer 
1. Editor and Reviewer: Health Prospect, Journal of Public Health (ISSN: 2091-2021) 
https://www.nepjol.info/index.php/HPROSPECT. 
2. Reviewer: Journal of Human Hypertension (ISSN 1476-5527) 
https://www.nature.com/jhh/ . 
3. Reviewer: Center for Disease Control and Preventions’ Preventing Chronic Disease, 
(https://www.cdc.gov/pcd/about_the_journal/index.htm). 
4. Reviewer: Journal of Geriatric Medicine and Gerontology 
(https://www.clinmedjournals.org/Journal-of-Geriatric-Medicine-and-Gerontology.php).  
5. Reviewer: World Research Journal of Cardiology (ISSN: 2321-4422 & E-ISSN) 2015- 
2018. 
6. Reviewer: AIDS Education and Prevention https://guilfordjournals.com/loi/aeap. 
7. Reviewer: Current Research in Nutrition and Food Science 
www.foodandnutritionjournal.org 
8. Reviewer: Sexual and Relationship Therapy  
https://www.tandfonline.com/toc/csmt20/current  
9. Reviewer: Journal of International Medical Research 
https://journals.sagepub.com/home/imr  
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10. Abstract Reviewer:  50th Anniversary Meeting of the Society for Epidemiologic 
Research. 
Community Service 
1. Graduate Liaison Officer: Public Health Student Association, University of Nevada Las 
Vegas, 2017-2018. 
2. School of Community Health Sciences Representative: Graduate and Professional 
Student Association (GPSA), Summer 2016 and 2017. 
3. Treasurer: Nepalese Students Association, University of Nevada Las Vegas, 2015-2017. 
Honors and Awards 
Awards 
1. UNLV Graduate College Spring 2019 Medallion Recipient, Las Vegas, May 2019. 
2. 2019 GPSA Merit Award, GPSA and Graduate College Annual Research Forum, Las 
Vegas, February 2019. 
3. Delta Omega Best Student Poster Award, Delta Omega National Meeting, San Diego, 
November 2018. 
4. Outstanding Graduate Student 2018, Department of Environment and Occupational 
Health, School of Community Health Sciences Honors Reception, UNLV, May 2018. 
5. Southern Gerontological Society Student Paper Award, 2018 Southern Gerontological 
Society and Georgia Gerontological Society Joint Conference, Buford, GA, April 14, 
2018. 
6. Selected for membership. Delta Omega, The Honor Society of Public Health, Delta Theta 
Chapter at UNLV, December 2017.  
7. Laurence G. Branch Doctoral Student Research Award, American Public Health 
Association Conference, Atlanta, GA, November 2017. 
8. Delta Omega Best Student Poster Award, Delta Omega National Meeting, Atlanta, GA, 
November 2017.  
9. Selected for Membership, The Honor Society of Phi Kappa Phi Chapter 100, April 2017. 
10. Outstanding Graduate Student 2017, Department of Environment and Occupational 
Health, School of Community Health Sciences Honors Reception, UNLV, May 2017. 
11. Honorable Mention: Outstanding Poster, “Nutritional Assessment of Older Adults in 
Nepal”; 18th Annual Graduate & Professional Student Research Forum, University of 
Nevada Las Vegas, March 12, 2016. 
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12. Mini Research Award 2071/2072, University Grants Commission, Sanothimi, Bhaktapur, 
Nepal, July 2015. 
13. First position with Distinction in Intermediate of Science (I.Sc.) (2001-2003), Siddhartha 
Vanasthali Institute, Tribhuvan University, Kathmandu, Nepal, May 2003. 
14. Girls Topper in Eastern Development Region- SLC 2000, Rumpum Excellency Awards, 
Kathmandu, Nepal, May 2000.  
Scholarships, Fellowships and Travel Awards 
1. 2019 Nevada Regents’ Scholar Awards - Graduate Students. 
2. UNLV Graduate and Professional Student Association (GPSA) Merit Award 2019. 
3. 2018-2019 President's UNLV Foundation Graduate Research Fellowship, University of 
Nevada, Las Vegas.  
4. 2018 Summer Doctoral Research Fellowships, University of Nevada, Las Vegas. 
5. UNLV Graduate and Professional Student Association (GPSA) Travel Sponsorship, 
November 2018, Boston, MA.   
6. UNLV School of Community Health Sciences - Conference Travel award for APHA 
meeting, November 2018. San Diego, CA. 
7. Southern Gerontological Society Student Scholarship Award, 2018 Southern 
Gerontological Society and Georgia Gerontological Society Joint Conference, Buford, 
GA, April 2018. 
8. UNLV School of Community Health Sciences - Conference Travel award for Southern 
Gerontological Society and Georgia Gerontological Society Joint Conference, April 2018. 
Buford, GA. 
9. Society for Epidemiologic Research (SER) “SPC Travel Scholarship” Seattle, WA, Jun 
2017. 
10. UNLV School of Community Health Sciences - Conference Travel award for SER 
meeting, June 2017. Seattle, WA. 
Professional Affiliations 
1. Member: American Public Health Association, 2017, 2018. 
2. Member: The Gerontological Society of America, 2018. 
3. Member: Society for Epidemiologic Research, 2016. 
4. Member: Nevada Public Health Association, 2016. 
5. Member: Nepal Public Health Association, 2012-Present. 
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6. Member: Nepal Health Professional Council (Council Registration No: 28 Jan PH), 2012-
Present. 
7. Member: University of Wolverhampton Alumni Association, 2011-Present. 
8. Member: Tribhuvan University Alumni Association, 2008 –Present. 
Students mentored 
1. Saroj Rimal, Bachelor’s in Public Health (BPH) Thesis Mentee (2014), currently 
employed by Ministry of Health and Population, Nepal Government.   
2. Ramlal Thaguna, BPH Thesis Mentee (2014), currently employed by Ministry of Health 
and Population, Nepal Government.   
3. Kiran Budathoki, BPH Thesis Mentee (2014), currently employed by Ministry of Health 
and Population, Nepal Government.   
4. Sudarsan Dhungana, BPH Thesis Mentee (2013), currently Field Coordinator for Action 
Nepal, Non-governmental organization.   
Technical/Software Skills 
Proficient in Microsoft Office, MS Access, Endnote, Epidata, Epi Info, SPSS, SAS, STATA, 
familiar with R. 
